<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Plants (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Plants (Basel)</journal-id><journal-id journal-id-type="publisher-id">plants</journal-id><journal-title-group><journal-title>Plants</journal-title></journal-title-group><issn pub-type="epub">2223-7747</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7823815</article-id><article-id pub-id-type="pmid">33375282</article-id><article-id pub-id-type="doi">10.3390/plants10010041</article-id><article-id pub-id-type="publisher-id">plants-10-00041</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Sterols and Triterpenes: Antiviral &#x000a0;&#x000a0;&#x000a0; Potential Supported by In-Silico Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hisham Shady</surname><given-names>Nourhan</given-names></name><xref ref-type="aff" rid="af1-plants-10-00041">1</xref><xref ref-type="author-notes" rid="fn1-plants-10-00041">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Youssif</surname><given-names>Khayrya A.</given-names></name><xref ref-type="aff" rid="af2-plants-10-00041">2</xref><xref ref-type="author-notes" rid="fn1-plants-10-00041">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1442-183X</contrib-id><name><surname>Sayed</surname><given-names>Ahmed M.</given-names></name><xref ref-type="aff" rid="af3-plants-10-00041">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7040-4500</contrib-id><name><surname>Belbahri</surname><given-names>Lassaad</given-names></name><xref ref-type="aff" rid="af4-plants-10-00041">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4688-2582</contrib-id><name><surname>Oszako</surname><given-names>Tomasz</given-names></name><xref ref-type="aff" rid="af5-plants-10-00041">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0174-4434</contrib-id><name><surname>Hassan</surname><given-names>Hossam M.</given-names></name><xref ref-type="aff" rid="af3-plants-10-00041">3</xref><xref ref-type="aff" rid="af6-plants-10-00041">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1014-6922</contrib-id><name><surname>Abdelmohsen</surname><given-names>Usama Ramadan</given-names></name><xref ref-type="aff" rid="af1-plants-10-00041">1</xref><xref ref-type="aff" rid="af7-plants-10-00041">7</xref><xref rid="c1-plants-10-00041" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-plants-10-00041"><label>1</label>Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, Universities Zone, P.O. Box 61111, New Minia City, Minia 61519, Egypt; <email>noura_shady2013@yahoo.com</email></aff><aff id="af2-plants-10-00041"><label>2</label>Department of Pharmacognosy, Faculty of Pharmacy, Modern University for Technology and Information, Cairo 11865, Egypt; <email>khayrya.youssif@gmail.com</email></aff><aff id="af3-plants-10-00041"><label>3</label>Department of Pharmacognosy, Faculty of Pharmacy, Nahda University, Beni-Suef 62513, Egypt; <email>ahmedpharma8530@gmail.com</email> (A.M.S.); <email>abuh20050@yahoo.com</email> (H.M.H.)</aff><aff id="af4-plants-10-00041"><label>4</label>Laboratory of Soil Biology, University of Neuchatel, 2000 Neuchatel, Switzerland; <email>lassaad.belbahri@unine.ch</email></aff><aff id="af5-plants-10-00041"><label>5</label>Departement of Forest Protection, Forest Research Institute, 05-090 S&#x00119;kocin Stary, Poland; <email>T.Oszako@ibles.waw.pl</email></aff><aff id="af6-plants-10-00041"><label>6</label>Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt</aff><aff id="af7-plants-10-00041"><label>7</label>Department of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt</aff><author-notes><corresp id="c1-plants-10-00041"><label>*</label>Correspondence: <email>usama.ramadan@mu.edu.eg</email>; Tel.: +2-86-2347759</corresp><fn id="fn1-plants-10-00041"><label>&#x02020;</label><p>Equal contribution.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><volume>10</volume><issue>1</issue><elocation-id>41</elocation-id><history><date date-type="received"><day>03</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>19</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) caused severe panic all over the world. The coronavirus (COVID-19) outbreak has already brought massive human suffering and major economic disruption and unfortunately, there is no specific treatment for COVID-19 so far. Herbal medicines and purified natural products can provide a rich resource for novel antiviral drugs. Therefore, in this review, we focused on the sterols and triterpenes as potential candidates derived from natural sources with well-reported in vitro efficacy against numerous types of viruses. Moreover, we compiled from these reviewed compounds a library of 162 sterols and triterpenes that was subjected to a computer-aided virtual screening against the active sites of the recently reported SARS-CoV-2 protein targets. Interestingly, the results suggested some compounds as potential drug candidates for the development of anti-SARS-CoV-2 therapeutics.</p></abstract><kwd-group><kwd>sterols</kwd><kwd>triterpenes</kwd><kwd>antiviral potential</kwd><kwd>SARS-CoV-2</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-plants-10-00041"><title>1. Introduction</title><p>Steroids and triterpenes are considered common natural product classes that are widespread in different marine and terrestrial natural sources (e.g., plants, animals, and microorganisms) [<xref rid="B1-plants-10-00041" ref-type="bibr">1</xref>,<xref rid="B2-plants-10-00041" ref-type="bibr">2</xref>,<xref rid="B3-plants-10-00041" ref-type="bibr">3</xref>]. Additionally, they comprise many sub-classes with enormous chemical diversity. These two classes of compounds have been provided several successful drugs for various ailments since the discovery of digoxin in 1785, like cortisol, fusidic acid, carbenoxolone, and &#x003b2;-Aescin [<xref rid="B4-plants-10-00041" ref-type="bibr">4</xref>]. These compounds possess a myriad of biological activities, digoxin used in the treatment of heart failure and atrial fibrillation [<xref rid="B5-plants-10-00041" ref-type="bibr">5</xref>], fusidic acid used as topical antibiotics [<xref rid="B6-plants-10-00041" ref-type="bibr">6</xref>]. Carbenoxolone enhances peripheral insulin sensitivity [<xref rid="B7-plants-10-00041" ref-type="bibr">7</xref>] and treatment of gastric ulcer [<xref rid="B8-plants-10-00041" ref-type="bibr">8</xref>] and &#x003b2;-Aescin used in the treatment of human hepatocellular carcinoma SMMC-7721 cells [<xref rid="B9-plants-10-00041" ref-type="bibr">9</xref>]. Steroids and triterpenes possess various potential antiviral properties such as anti-Herpes simplex virus activity [<xref rid="B10-plants-10-00041" ref-type="bibr">10</xref>], anti-hepatitis B activity [<xref rid="B11-plants-10-00041" ref-type="bibr">11</xref>], anti-HIV1 and 2, AIDS, and hepatitis C virus activities [<xref rid="B12-plants-10-00041" ref-type="bibr">12</xref>]. Steroids class consists of 25 chemical subclasses with about 11,825 compounds that have been previously reported [<xref rid="B13-plants-10-00041" ref-type="bibr">13</xref>] (<xref ref-type="fig" rid="plants-10-00041-f001">Figure 1</xref>A) While, triterpenoids class of compounds consists of 47 chemical subclasses with about 18,864 chemical compounds that were previously, isolated, and identified from different natural sources as shown in (<xref ref-type="fig" rid="plants-10-00041-f001">Figure 1</xref>B).</p><p>Many representatives from both classes (i.e., steroids and triterpenoids) have been reported for a wide spectrum of pharmacological activity (e.g., antimicrobial, anticancer, and anti-inflammatory activities) (<xref ref-type="fig" rid="plants-10-00041-f002">Figure 2</xref>). Our current review aims to shed light on the antiviral potential of these interesting secondary metabolites classes (i.e., steroids and triterpenes) illustrating their mode of actions either directly (i.e., direct viral inhibition) or indirectly (i.e., boosting the host immune response, reducing the inflammatory and antagonize some host-based molecular targets used by viruses for cell entry and multiplication). We also investigated the probability of these reviewed triterpenes and sterols to provide promising candidates for the development of effective therapeutics towards the current SARS-CoV-2 pandemic by molecular docking experiments against the currently available protein targets (either viral or human-based targets).</p></sec><sec sec-type="methods" id="sec2-plants-10-00041"><title>2. Methodology</title><sec id="sec2dot1-plants-10-00041"><title>2.1. Databases</title><p>The review article search was conducted in the following databases: Research gate (<uri xlink:href="https://www.researchgate.net/search">https://www.researchgate.net/search</uri>), Science Direct (<uri xlink:href="https://www.sciencedirect.com">https://www.sciencedirect.com</uri>), PubMed (<uri xlink:href="https://pubmed.ncbi.nlm.nih.gov">https://pubmed.ncbi.nlm.nih.gov</uri>), Scopus (<uri xlink:href="https://www.scopus.com">https://www.scopus.com</uri>), Web of Science (<uri xlink:href="https://clarivate.libguides.com/webofscienceplatform/alldb">https://clarivate.libguides.com/webofscienceplatform/alldb</uri>), Google Scholar (<uri xlink:href="https://scholar.google.com">https://scholar.google.com</uri>), and DNP (Dictionary of Natural Products) database. The keywords &#x0201c;antiviral steroids and triterpenes&#x0201d; were paired with &#x0201c;natural products&#x0201d;, &#x0201c;marine drugs&#x0201d;, &#x0201c;medicinal plants&#x0201d;, &#x0201c;herbal drugs&#x0201d;, &#x0201c;crude extracts&#x0201d;, &#x0201c;fungi&#x0201d;, or &#x0201c;synthetic derivatives of natural products&#x0201d; to obtain published records till 2020. </p></sec><sec id="sec2dot2-plants-10-00041"><title>2.2. Molecular Docking</title><p>Docking study was carried out against all available crystal structure (<xref ref-type="fig" rid="plants-10-00041-f002">Figure 2</xref>) of SARS CoV-2 proteins (3 proteins) in Protein Data Bank (PDB) (along with other four human proteins (4 proteins) involved in the entry and possessing of the virus (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref>) using Autodock Vina docking machine [<xref rid="B14-plants-10-00041" ref-type="bibr">14</xref>]. The viral crystal structures are SARS-CoV-2 main protease (M<sup>pro</sup>) (PDB ID: 6LU7), papain-like protease (PL<sup>pro</sup>) (PDB ID: 6WXR)) which are key viral cysteine proteases essential for the viral replication inside the host cell, and viral ADP ribose phosphatase (ARP) (PDB ID: 6W02) which is essential for the viral protection against the ADP-ribosylation activated by the innate immune system of the host cells. The four human targets are adaptor protein 2 associated kinase.</p><p>(AAK1) (PDB ID: 4WSQ) and cyclin G-associated kinase (GAK) (PDB ID: 4Y8D) are two important proteins for the viral entry into the host cell [<xref rid="B15-plants-10-00041" ref-type="bibr">15</xref>]. Moreover, the two host-based proteases furin (PDB ID: 6EQX) and cathepsin L (PDB ID: 2YJC) that are involved in viral spike protein (S-protein) activation).</p><p>The applied docking protocol deals with the protein as a rigid structure and the tested compound as a flexible structure during its computations. The co-crystallized ligands were used to determine the binding sites. The ligand-to-binding-site shape matching root means square (RMSD) threshold was set to 2.0 &#x000c5;. The interaction energies were determined using the Charmm Force Field (v.1.02) with 10.0 &#x000c5; as a non-bonded cutoff distance and distance-dependent dielectric. Then, 5.0 &#x000c5; was set as an energy grid extending from the binding site. The tested compounds were energy-minimized inside the selected binding pocket. The editing and visualization of the generated binding poses were performed using Pymol software [<xref rid="B16-plants-10-00041" ref-type="bibr">16</xref>].</p></sec></sec><sec id="sec3-plants-10-00041"><title>3. Findings and Discussion</title><sec id="sec3dot1-plants-10-00041"><title>3.1. Anti-HIV Agents</title><p>Sterol and triterpenes reported as anti-HIV candidates have been reported extensively in the literature, where they exhibited multiple modes of action as antiviral.</p><sec id="sec3dot1dot1-plants-10-00041"><title>3.1.1. Reverse Transcriptase Inhibitors</title><p>Reverse transcriptase is a key enzyme in retroviruses like HIV (i.e., essential for the viral replication process), and hence it has been extensively studied for the development of anti-HIV therapeutics. Several sterols and triterpenes have been reported as potent HIV reverse transcriptase inhibitors during the last 20 years.</p><p>Stigmastanol (<bold>1</bold>) is a common sterol in many plants and present in large quantities in rice bran, where it can be easily isolated and purified. This sulfated sterol has been reported to inhibit HIV-&#x02019;s reverse transcriptase competitively with IC<sub>50</sub> = 3.9 &#x003bc;M. [<xref rid="B17-plants-10-00041" ref-type="bibr">17</xref>]. Clathsterol (<bold>2</bold>) the major sterol in <italic>Clathria</italic> species has been found to inhibit HIV-1 reverse transcriptase activity at a concentration of 10&#x000b5;M [<xref rid="B18-plants-10-00041" ref-type="bibr">18</xref>]. Furthermore, concise synthesis of the clathsterol steroidal core has also been explained [<xref rid="B19-plants-10-00041" ref-type="bibr">19</xref>].</p><p>Both &#x003b1;, &#x003b2;- amyrenone (3) are triterpene derivatives of the ursane and oleanane series, as shown in (<xref ref-type="fig" rid="plants-10-00041-f003">Figure 3</xref>). They were commonly isolated from Burseraceae family species such as <italic>Protium heptaphyllum</italic>, <italic>Protium. opacum</italic> var. <italic>opacum</italic>, <italic>Protium. giganteum</italic>; <italic>Trattinnickia glaziovii</italic>, and <italic>Trattinnickia. peruviana</italic>. </p><p>Both compounds have been reported to possess several pharmacological effects (e.g., anti-inflammatory, antinociceptive activities together with lipase, &#x003b1;-glucosidase, and &#x003b1;-amylase, inhibitory activities) [<xref rid="B20-plants-10-00041" ref-type="bibr">20</xref>]. In addition, &#x003b1;-amyrenone has also shown strong virucidal activity against HIV-1 reverse transcriptase in a low IC<sub>50</sub> value equal to 3.3 &#x000b5;M.</p><p>Bryonolic acid (4) is a pentacyclic triterpenoid found in the family Cucurbitaceae. It has many remarkable potentials for the treatment of different diseases (e.g., allergic and inflammatory diseases) [<xref rid="B21-plants-10-00041" ref-type="bibr">21</xref>,<xref rid="B22-plants-10-00041" ref-type="bibr">22</xref>]. Additionally, it has shown anti-HIV activity by inhibiting the reverse transcriptase enzyme (IC<sub>50</sub> 5.3 &#x000b5;M) [<xref rid="B23-plants-10-00041" ref-type="bibr">23</xref>].</p><p>Butyrospermol (5) and Isotirucallol (6) are euphane and dammarane types triterpenes, respectively (<xref ref-type="fig" rid="plants-10-00041-f003">Figure 3</xref>). Both compounds have been reported to be major metabolites in <italic>Camellia japonica</italic> and <italic>Camellia. sasanqua</italic>. Moreover, they were able to inhibit HIV-1 reverse transcriptase with IC<sub>50</sub> values of 3.1 &#x000b5;M and 3.5 &#x000b5;M, respectively [<xref rid="B17-plants-10-00041" ref-type="bibr">17</xref>].</p><p>Another potent inhibitor of the HIV-1 reverse transcriptase enzyme is calenduladiol (7), which is a lupine type pentacyclic triterpene that found in <italic>Calendula officinalis.</italic> Calenduladiol could potentially inhibit the viral HIV-1 reverse transcriptase with IC<sub>50</sub> equal to 5.4 &#x000b5;M.</p><p>Two active cycloartane type pentacyclic triterpenes compounds of rice bran, cycloartenol ferulate (8), and 24-Methylenecycloartanol ferulate (9) displayed potent anti-HIV through competitive inhibition of reverse transcriptase with (IC<sub>50</sub> 2.2 &#x000b5;M and 1.9 &#x000b5;M, respectively) [<xref rid="B17-plants-10-00041" ref-type="bibr">17</xref>].</p><p>Erythrodiol (10), is the precursor of pentacyclic triterpenic acids that were isolated from <italic>Olea europaea</italic>. This compound has displayed antiviral activity against HIV-1 reverse transcriptase with an IC<sub>50</sub> value of 5 &#x000b5;M. </p><p>1&#x003b2;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11), a pentacyclic triterpene as shown in (<xref ref-type="fig" rid="plants-10-00041-f001">Figure 1</xref>), was isolated from <italic>Maprounnea Africana</italic>. The compound is considered a potent inhibitor of HIV-1 reverse transcriptase with IC<sub>50</sub> 3.7 &#x000b5;M [<xref rid="B24-plants-10-00041" ref-type="bibr">24</xref>].</p><p>Lupeol (12) is a pentacyclic triterpene that is widely distributed in edible vegetables and fruits. Research over about three decades has displayed numerous remarkable pharmacological activities of lupeol. Several in vitro and preclinical animal studies have suggested potential anti-inflammatory, immunomodulatory, antiproliferative, and cholesterol-lowering agents [<xref rid="B25-plants-10-00041" ref-type="bibr">25</xref>,<xref rid="B26-plants-10-00041" ref-type="bibr">26</xref>,<xref rid="B27-plants-10-00041" ref-type="bibr">27</xref>,<xref rid="B28-plants-10-00041" ref-type="bibr">28</xref>,<xref rid="B29-plants-10-00041" ref-type="bibr">29</xref>,<xref rid="B30-plants-10-00041" ref-type="bibr">30</xref>,<xref rid="B31-plants-10-00041" ref-type="bibr">31</xref>]. The anti-inflammatory and immunomodulatory activity of this compound has been linked to its regulation of several cytokines expression (e.g., like IL-2, IL4, IL5, Il&#x003b2;), [<xref rid="B30-plants-10-00041" ref-type="bibr">30</xref>], and hence it can help as an adjuvant therapeutic agent in the treatment of COVID-19 to control the cytokine storm associated with this pandemic disease [<xref rid="B32-plants-10-00041" ref-type="bibr">32</xref>].</p><p>Furthermore, Akihisa et al. reported that lupeol strongly can inhibit HIV-1 reverse transcriptase in IC<sub>50</sub> value of 3.8 &#x000b5;M [<xref rid="B16-plants-10-00041" ref-type="bibr">16</xref>].</p><p>Salaspermic acid (13), and oleanane type triterpene derivative that has been found to act as an inhibitor of HIV reverse transcriptase in H9 lymphocyte cells (IC<sub>50</sub> 10 &#x000b5;M). This triterpene has been reported as the major metabolite of the roots of <italic>Triterygium wilfordii</italic> [<xref rid="B33-plants-10-00041" ref-type="bibr">33</xref>,<xref rid="B34-plants-10-00041" ref-type="bibr">34</xref>].</p><p>Uvaol (14), an olive-derived lupine type pentacyclic triterpene, was also found to inhibit HIV maturation through inhibiting HIV-1 reverse transcriptase in IC<sub>50</sub> value of 9.5 &#x000b5;M [<xref rid="B35-plants-10-00041" ref-type="bibr">35</xref>].</p></sec><sec id="sec3dot1dot2-plants-10-00041"><title>3.1.2. Protease Inhibitors</title><p>Proteases are common viral hydrolytic enzymes. They are usually involved in viral entry and initiation of the viral replication process. Additionally, other human-based proteases are utilized by the majority of infectious viruses in their host cell attachment and entry [<xref rid="B36-plants-10-00041" ref-type="bibr">36</xref>]. Thus, pan-protease inhibitors (e.g., camostat) have shown broad-spectrum antiviral activity including the currently spread SARS-CoV-2 [<xref rid="B36-plants-10-00041" ref-type="bibr">36</xref>].</p><p>Some lanostane-type triterpenes isolated from the medicinal mushrooms <italic>Ganoderma</italic> species have been shown in vitro inhibitory effects against HIV-1 protease. For example, 3&#x003b2;-5&#x003b1;-dihydroxy-6&#x003b2;-methoxyergosta-7,22-diene (15) (<xref ref-type="fig" rid="plants-10-00041-f004">Figure 4</xref>) [<xref rid="B37-plants-10-00041" ref-type="bibr">37</xref>] was isolated from an edible mushroom species called <italic>G. lucidum</italic> and was reported as a potent non-competitive HIV-1 protease inhibitor (IC<sub>50</sub> = 7.8 &#x000b5;M). Additionally, three <italic>G.colosum</italic>-derived lanostane type triterpenes namely, colossolactones E, G, and V (16&#x02013;18) (<xref ref-type="fig" rid="plants-10-00041-f004">Figure 4</xref>) [<xref rid="B38-plants-10-00041" ref-type="bibr">38</xref>] as having been displayed anti-HIV-1 protease with IC<sub>50</sub> values ranged from 5 to 9 &#x000b5;M, respectively.</p><p>In addition to being a potent HIV reverse transcriptase [<xref rid="B34-plants-10-00041" ref-type="bibr">34</xref>], uvaol (14) was also found to inhibit HIV-1 protease with an IC<sub>50</sub> value of 3.5 &#x000b5;M [<xref rid="B35-plants-10-00041" ref-type="bibr">35</xref>].</p></sec><sec id="sec3dot1dot3-plants-10-00041"><title>3.1.3. DNA Polymerase Inhibitors</title><p>The <italic>Maprounnea africana</italic>-derived pentacyclic triterpene,1&#x003b2;-hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11) has been also revealed potent inhibitory activity toward DNA polymerase with IC<sub>50</sub> equal to 7.4 &#x000b5;M in addition to its anti-HIV-1 reverse transcriptase activity [<xref rid="B24-plants-10-00041" ref-type="bibr">24</xref>].</p></sec></sec><sec id="sec3dot2-plants-10-00041"><title>3.2. Replication Inhibitors:</title><p>&#x003b2;-Aescin (19) is a pentacyclic triterpene that was isolated from <italic>Aesculus hippocastranum</italic> (Hippocastanaceae) seed extract. &#x003b2;-Aescin was reported to exhibit anti-oedematous, anti-inflammatory, and antioxidative effects [<xref rid="B39-plants-10-00041" ref-type="bibr">39</xref>,<xref rid="B40-plants-10-00041" ref-type="bibr">40</xref>]. It has been reported that &#x003b2;-Aescin inhibits NF- <italic>&#x00199;</italic>B activation and cytokines production in LPS-treated mice and numerous tumor cells, macrophages, and endothelial cells [<xref rid="B41-plants-10-00041" ref-type="bibr">41</xref>,<xref rid="B42-plants-10-00041" ref-type="bibr">42</xref>]. Additionally, this inhibition was also found to play an important role in inhibiting Herpes Simplex virus-1 (HSV-1) replication with an IC<sub>50</sub> value of 1.5 and 2.4 &#x000b5;M was calculated in Human corneal-limbal epithelial (HCLE) and normal human conjunctival epithelial cell line (NHC) cells. The virucidal activity of &#x003b2;-aescin could be due to its ability to interfere with cell membranes and cholesterol homeostasis. </p><p>Moreover, this glycosylated triterpene (i.e., &#x003b2;-aescin) has been also reported to inhibit the replication of SARS-CoV-1 in vitro (IC<sub>50</sub> 6 &#x000b5;M).</p><p>Asiatic acid (20) is a naturally occurring aglycone of ursane-type pentacyclic triterpenoids. It has been previously reported from a wide range of plants e.g., <italic>Actinida argute</italic> roots, <italic>Centella Asiatica</italic> leaves, and <italic>Combretum laxum</italic> Stems [<xref rid="B43-plants-10-00041" ref-type="bibr">43</xref>]. It has poly-pharmacological properties like antioxidant, anti-inflammatory. Moreover, it affects and regulates apoptosis that contributes to its therapeutic effects in various diseases. Numerous in vivo and in vitro studies reported that asiatic acid (20) influences many enzymes, receptors, growth, and transcription factors, in addition to several cell signaling cascades. Moreover, it inhibits both HIV-1 and enterovirus 71 (EV71) replications in acutely infected host cells with IC<sub>50</sub> equal to 9 and 20 &#x000b5;M, respectively [<xref rid="B43-plants-10-00041" ref-type="bibr">43</xref>,<xref rid="B44-plants-10-00041" ref-type="bibr">44</xref>].</p><p>The triterpene lactone lancilactones C (21), which was isolated from the roots of <italic>Kadsura lancilimba</italic> (Schizandraceae), has been inhibited HIV replication with an IC<sub>50</sub> value of 1.4 &#x000b5;M [<xref rid="B45-plants-10-00041" ref-type="bibr">45</xref>]. </p><p>Oleanolic acid (OA) (22) is a pentacyclic triterpenoid that possesses a variety of interesting biological activities (e.g., anticancer, antimicrobial, and anti-inflammatory activities) [<xref rid="B46-plants-10-00041" ref-type="bibr">46</xref>]. This common triterpene has been previously reported from more than 1600 different plant species [<xref rid="B47-plants-10-00041" ref-type="bibr">47</xref>,<xref rid="B48-plants-10-00041" ref-type="bibr">48</xref>]. OA has been found to inhibit HIV-1 replication in acutely infected H9 lymphocyte cells (IC<sub>50</sub> 7.5&#x000b5;M) [<xref rid="B44-plants-10-00041" ref-type="bibr">44</xref>,<xref rid="B49-plants-10-00041" ref-type="bibr">49</xref>]. synthesized derivatives of OA by the modification of C12-C13 double bond yielding a series of new compounds that was 3-fold more active than OA [<xref rid="B49-plants-10-00041" ref-type="bibr">49</xref>].</p><p>Platanic acid (23) is a pentacyclic triterpenoid as shown in (<xref ref-type="fig" rid="plants-10-00041-f005">Figure 5</xref>), that was isolated from the leaves of <italic>Syzigium claviflorum</italic> (Myrtaceae) [<xref rid="B33-plants-10-00041" ref-type="bibr">33</xref>]. It showed an inhibitory effect on HIV replication with an IC<sub>50</sub> of 6.5 &#x000b5;M, while its IC<sub>50</sub> for inhibition of uninfected H9 cell growth was 90 &#x000b5;M. </p><p>Salaspermic acid (13) is an oleanane-type triterpene derivative, which was isolated from the roots of <italic>Triterygium wilfordii</italic> [<xref rid="B33-plants-10-00041" ref-type="bibr">33</xref>,<xref rid="B34-plants-10-00041" ref-type="bibr">34</xref>]. It was previously mentioned to have inhibitory activity against HIV reverse transcriptase. Moreover, it has an anti-HIV replication in H9 lymphocyte cells with an IC<sub>50</sub> value of 10 &#x000b5;M. </p><p>Another lanostane-type triterpene namely, suberosol (24) has shown inhibitory activity against HIV replication in H9 lymphocyte cells with IC<sub>50</sub> equal to 3 &#x000b5;M. This compound has been previously isolated from <italic>Polyalthia suberosa</italic> (Annonaceae) [<xref rid="B50-plants-10-00041" ref-type="bibr">50</xref>].</p></sec></sec><sec id="sec4-plants-10-00041"><title>4. Other Compounds with Antiviral Activity</title><p>Halistanol sulfate F (25) and halistanol sulfate G (26) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) are two steroid sulfate oxoanions that exhibited antiviral activity against HIV-1, with EC<sub>50</sub> = 3.6 &#x000b5;M, respectively, and were previously isolated from <italic>Psedaxinissa digitate</italic> [<xref rid="B51-plants-10-00041" ref-type="bibr">51</xref>]. </p><p>Additionally, orthoesterol A, B and C disulfate (27&#x02013;29) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) were sterol disulfate orthoester, were previously, isolated from the marine sponge <italic>Petrosia weinbergi</italic> and showed activities against feline leukemia virus in vitro (EC<sub>50</sub> = 1.0, 1.3, and 1.0 &#x000b5;g/mL), respectively [<xref rid="B52-plants-10-00041" ref-type="bibr">52</xref>]. </p><p>Alphitolic acid (30) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) is an ursan-type pentacyclic triterpene, that was isolated from <italic>Rosa woodsii</italic> (F. Rosaceae). It has shown anti-HIV activity with EC<sub>50</sub> of 4 &#x000b5;M [<xref rid="B44-plants-10-00041" ref-type="bibr">44</xref>]. Moreover, it exhibits a strong inhibition against acute inflammation induced by carrageenan and xylene, this effect is quite similar to that of dexamethasone. Studies suggested that alphitolic acid anti-inflammatory activity may be due to inhibition of the nuclear factor kappa-B (NF-&#x003ba;B), or suppressing the secretion of pro-inflammatory cytokines (e.g., tumor necrosis factor-&#x003b1;, interleukin-1&#x003b2;, interleukin-8, interleukin-6) [<xref rid="B53-plants-10-00041" ref-type="bibr">53</xref>]. Such cytokines suppressor effect of alphitolic acid (30) can help in reducing the severe inflammatory syndrome associated with COVID-19, which is the major cause of the high mortality rate reported for this disease [<xref rid="B32-plants-10-00041" ref-type="bibr">32</xref>].</p><p>Betulinic acid (BetA) (31) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) is a pentacyclic lupine type triterpene, which has been reported to display broad-spectrum antiviral activity (e.g., HIV and HSV) [<xref rid="B54-plants-10-00041" ref-type="bibr">54</xref>]. This compound is recovered from the bark of birch trees and other pants e.g., leaves of <italic>Sizigium claviflorum</italic> in high quantity. Esterification of BetA has yielded some semisynthetic derivatives (e.g., 3-acyl derivatives and the ester analog 3-<italic>O</italic>-(3&#x02032;,3&#x02032;-dimethylsuccinyl) that were more potent inhibitors (EC<sub>50</sub> 1.4 &#x000b5;M) against HIV-1. BetA antiviral mode of action was proposed to be by the interference with normal gag processing, which is crucial for the formation of mature infectious virus particles. The C-3 position of betulinic acid analogs was found to be a pharmacophore for anti-HIV maturation activity, and optimal potency, it was found that the analog should have a C-3 acyl side with the proper length, terminal carboxylic acid moiety, and dimethyl substitution at the C-3&#x02018; position [<xref rid="B55-plants-10-00041" ref-type="bibr">55</xref>,<xref rid="B56-plants-10-00041" ref-type="bibr">56</xref>]. BetA derivatives substituted with &#x003c9;-aminoalcanoic acid at the C-28 position showed higher anti-HIV activity in the nanomolar range via interfering with the virus-cell fusion process [<xref rid="B57-plants-10-00041" ref-type="bibr">57</xref>]. So, The C-28 position of BetA has been considered as a pharmacophore for inhibition of HIV entry. Additionally, the addition of the acyl side chain at C-3 and the amide side chain at C-28 to BetA resulted in derivatives that prohibited both HIV entry and maturation [<xref rid="B58-plants-10-00041" ref-type="bibr">58</xref>]. Betulinic acid-derived compounds, especially the 3,28-di-oacetylbetulin inhibited Semliki Forest virus (SFV) replication during plaque reduction assay [<xref rid="B59-plants-10-00041" ref-type="bibr">59</xref>]. One of the most important structural contributors to the anti-SFV activity is the free or acetylated OH group at C-3. The antiviral activity of betulinic acid and its derivatives also has been studied against influenza A, herpes simplex type 1 (HSV-1), and ECHO-6 enterovirus (EC<sub>50</sub> 1.3 &#x000b5;M; EC<sub>50</sub> 5.1 &#x000b5;M; EC<sub>50</sub> 0.9 &#x000b5;M, respectively) [<xref rid="B59-plants-10-00041" ref-type="bibr">59</xref>,<xref rid="B60-plants-10-00041" ref-type="bibr">60</xref>]. It has been found that the addition of ureides or the C-28 amide group to betulinic acid increases its anti-HSV-1 activity [<xref rid="B61-plants-10-00041" ref-type="bibr">61</xref>,<xref rid="B62-plants-10-00041" ref-type="bibr">62</xref>]. Moreover, the 3-oxime derivatives of betulinic acid were more active than betulinic acid against the influenza A virus with EC<sub>50</sub> of 2.8 &#x000b5;M [<xref rid="B43-plants-10-00041" ref-type="bibr">43</xref>], whereas betulinic aldehyde showed antiviral activity against the H9N2 subtype of the avian influenza virus [<xref rid="B48-plants-10-00041" ref-type="bibr">48</xref>]. Another betulinic acid derivative called 3&#x003b2;,28-di-onicotinoylbetulin is active against human papillomavirus (HPV) type 11 with an IC<sub>50</sub> value of 12.4 &#x000b5;M type [<xref rid="B49-plants-10-00041" ref-type="bibr">49</xref>]. </p><p>Dammaradienol, dammarenolic acid, hydroxydammarenone I, and hydroxyhopanone (32&#x02013;35) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) are four seco-dammarane type triterpenes that have been isolated from <italic>Balanocarpus heimii</italic> (Dipterocarpaceae) and <italic>Dipterocarpus alatus</italic> resin; the two compounds possess antiviral activity against HSV-1 with IC<sub>50</sub> values equal to 2.5 &#x000b5;M, 3 &#x000b5;M, 2 &#x000b5;M, and 7 &#x000b5;M, respectively, and HSV-2 virus (3 &#x000b5;M, 2 &#x000b5;M, 5 &#x000b5;M, and 5 &#x000b5;M), respectively [<xref rid="B33-plants-10-00041" ref-type="bibr">33</xref>]. </p><p>Glycyrrhizin (36) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) is a common triterpenoid saponin glycoside found in <italic>Glycyrrhiza glabra</italic> roots. It was used as a sweetener and flavoring agent in folk medicine [<xref rid="B63-plants-10-00041" ref-type="bibr">63</xref>]. The antiviral activity of glycyrrhizin and its related compounds were studied against a large variety of viruses. Glycyrrhizin and its metabolites such as glycyrrhetic acid (GA), which is a pentacyclic triterpene belong to the &#x003b2;-amyrin type obtained by hydrolysis of glycyrrhizin, reported having the ability to inhibit the cytopathic effect of numerous DNA and RNA viruses such as vaccinia, HSV-1, Newcastle disease, and vesicular stomatitis virus (VSV) in vitro [<xref rid="B64-plants-10-00041" ref-type="bibr">64</xref>]. Glycyrrhizin has been also shown in vitro antiviral activity against the varicella-zoster virus [<xref rid="B65-plants-10-00041" ref-type="bibr">65</xref>] in human embryonic fibroblasts with IC<sub>50</sub> equal 0.75 mM. Moreover, Glycyrrhizin has an inhibitory effect on human flaviviruses, such as Japanese encephalitis virus (JEV) dengue virus, tick-borne encephalitis virus (TBEV), West Nile virus (WNV), and many others (EC<sub>50</sub> equal to 384 &#x000b5;M; EC<sub>50</sub>: 474 &#x000b5;M; EC<sub>50</sub>: 229 &#x000b5;M, respectively) [<xref rid="B66-plants-10-00041" ref-type="bibr">66</xref>]. It was also reported that glycyrrhetic acid is active against EBV via interference with EBV entry into the host cells [<xref rid="B67-plants-10-00041" ref-type="bibr">67</xref>]. In vitro studies showed that glycyrrhizin stopped the secretion of HBV surface antigen (HBsAg) from hepatocytes infected with HBV [<xref rid="B68-plants-10-00041" ref-type="bibr">68</xref>]. It also prohibited the viral cytopathic effect and the virus-specific antigen expression in HIV-infected MT-4 cells and inhibited virus replication in cultures of leukocytes from HIV-infected patients in IC<sub>50</sub> equal to 0.3 mM) [<xref rid="B69-plants-10-00041" ref-type="bibr">69</xref>]. It worth mentioning that, glycyrrhizin can inhibit SARS CoV entry to Vero cells (EC<sub>50</sub>: 600 mg/L) [<xref rid="B70-plants-10-00041" ref-type="bibr">70</xref>] and H1N1 influenza virus uptake into human bronchial epithelial cells (EC<sub>50</sub>: 500 &#x000b5;M) [<xref rid="B71-plants-10-00041" ref-type="bibr">71</xref>]. The antiviral effect of glycyrrhizin against pseudorabies herpesvirus (PrV) was detected with IC<sub>50</sub> values ranged between (0 and 125 &#x000b5;M) [<xref rid="B72-plants-10-00041" ref-type="bibr">72</xref>], while glycyrrhetic acid inhibited in vitro rotavirus replication, and affected the virus entry into the cells [<xref rid="B73-plants-10-00041" ref-type="bibr">73</xref>]. It has been shown recently that, glycyrrhizin lead to loss of proper mRNA production and to cause a defect in sister chromatid cohesion in IC<sub>50</sub> equal to 2-4 mM, this process is necessary for both Kaposi&#x02018;s sarcoma-associated herpesvirus (KSHV) replication and cellular chromosome stability, which resulted in the inhibition of proliferation of B lymphocytes latently infected with KSHV [<xref rid="B74-plants-10-00041" ref-type="bibr">74</xref>]. Additionally, glycyrrhizin showed promising antiviral activity against the hepatitis C virus with IC<sub>50</sub> of 5 &#x000b5;M in hepatic cells transfecting with HCV 3a core plasmid [<xref rid="B75-plants-10-00041" ref-type="bibr">75</xref>]. </p><p>Pomolic acid (PA) (37) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) is a pentacyclic ursane-type triterpenoid and is considered the1 9-hydroxy derivative of ursolic acid [<xref rid="B76-plants-10-00041" ref-type="bibr">76</xref>]. It has been isolated from a wide range of plants e.g., <italic>Rosa woodsia</italic> (Rosaceae) and <italic>Hyptis capitata</italic> (Labiatae), it was also identified as an anti-HIV agent (EC<sub>50</sub> 1.4 &#x000b5;M). Studies showed that pomolic acid can also reduce carrageenan-induced paw edema in mice which indicates its strong anti-inflammatory activity. It can also inhibit the in vivo production of interleukin-1&#x003b2; by 39% [<xref rid="B77-plants-10-00041" ref-type="bibr">77</xref>]. </p><p>Three quinone-methide triterpenes, pristimererin, tingenone, and iguesterin (38&#x02013;40) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) have been isolated from <italic>Triterygium regelii</italic>. The three compounds were evaluated for their SARS-CoV 3CLpro inhibitory activities and showed potent inhibitory activities with IC<sub>50</sub> values of 5.5, 9.9, and 2.6 &#x000b5;M, respectively. Studies showed that the quinone-methide moiety in A-ring and increasing hydrophobicity in E-ring increase the virucidal potential [<xref rid="B78-plants-10-00041" ref-type="bibr">78</xref>]. Under the acidic conditions, the quinone-methide chromophore can rearrange to phenolic systems [<xref rid="B79-plants-10-00041" ref-type="bibr">79</xref>,<xref rid="B80-plants-10-00041" ref-type="bibr">80</xref>,<xref rid="B81-plants-10-00041" ref-type="bibr">81</xref>,<xref rid="B82-plants-10-00041" ref-type="bibr">82</xref>,<xref rid="B83-plants-10-00041" ref-type="bibr">83</xref>] and yield isomers which were found to have an inhibitory effect on HSV [<xref rid="B84-plants-10-00041" ref-type="bibr">84</xref>].</p><p>Saikosaponins (41) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) is a group of oleanane derivatives usually present as glucosides, in many medicinal plants e.g., <italic>Bupleurum</italic> spp., <italic>Heteromorpha</italic> spp., and <italic>Scrophularia scorodonia.</italic> Saikosaponins (A, B<sub>2</sub>, C, and D) have been proved to be active against human immunodeficiency virus (HIV) [<xref rid="B85-plants-10-00041" ref-type="bibr">85</xref>], measles [<xref rid="B86-plants-10-00041" ref-type="bibr">86</xref>], influenza virus [<xref rid="B77-plants-10-00041" ref-type="bibr">77</xref>,<xref rid="B78-plants-10-00041" ref-type="bibr">78</xref>] HSV, and varicella-zoster virus [<xref rid="B65-plants-10-00041" ref-type="bibr">65</xref>] Saikosaponin A has been reported to possess anti-HCoV-229E activity with an IC<sub>50</sub> value of 8.6 &#x000b5;M. Ursolic acid (UA) (42) (<xref ref-type="fig" rid="plants-10-00041-f006">Figure 6</xref>) is a naturally occurring pentacyclic triterpene carboxylic acid, with various pharmaceutical properties present as a free acid or as saponins. UA was isolated from <italic>Balanocarpus heimii</italic>. UA was found to have antiviral activity in <italic>in-vitro</italic> against rotavirus infections and It inhibited rotavirus replication in IC<sub>50</sub> of 10 &#x000b5;M [<xref rid="B87-plants-10-00041" ref-type="bibr">87</xref>]. It displayed partly anti-HCV activity through suppressing HCV NS5B RdRp activity as noncompetitive inhibitors. Therefore, ursolic acid is suggested to be used as potential HCV antivirals and can be applied to clinical trials either as monotherapy or in combination with other HCV antivirals [<xref rid="B88-plants-10-00041" ref-type="bibr">88</xref>].</p></sec><sec id="sec5-plants-10-00041"><title>5. In Silico Investigation </title><p>To suggest possible anti-SARS-CoV-2 candidates, the 162 compounds reviewed in this investigation were subjected to a docking study against both virus-based and human-based molecular targets (three and four targets, respectively) that their structures are currently available at protein data bank website (PDB, <uri xlink:href="https://www.rcsb.org/">https://www.rcsb.org/</uri>). Six triterpenes were retrieved as top hits for one or more targets depending on the binding energies they scored (i.e., got binding energy lower than &#x02212;6 kcal/mol) and their interactions with the reported key amino acid residues (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="plants-10-00041-f007">Figure 7</xref>). </p><p>Both SARS-CoV-2 main protease (M<sup>pro</sup>) and papain-like protease (PL<sup>pro</sup>) are key viral cysteine proteases essential for the viral replication inside the host cell, where they activate the replication complex that in turn initiate the viral RNA replication [<xref rid="B15-plants-10-00041" ref-type="bibr">15</xref>].</p><p>The triterpene 1&#x003b2;-hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11), which was previously isolated from the roots of <italic>Maprounea Africana</italic> [<xref rid="B89-plants-10-00041" ref-type="bibr">89</xref>], was the only compound that got interesting binding scores against the viral main protease (M<sup>pro</sup>) and papain-like protease(PL<sup>pro</sup>) (binding scores of &#x02212;8.5 and -8.0 kcal/mol, respectively, Table X). This compound was able to form four strong hydrogen bonds (&#x0003c;2.5 &#x000c5;) and with four different amino acid residues inside the M<sup>pro</sup>&#x02019;s active site (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="plants-10-00041-f008">Figure 8</xref>), three of them have been reported previously as essential ones for the enzyme&#x02019;s inhibition [<xref rid="B36-plants-10-00041" ref-type="bibr">36</xref>]. Additionally, it was able to form two hydrophobic interactions with HID-41 and PRO-168 that have been also reported to be involved in the interactions with the co-crystallized inhibitors. Regarding PL<sup>pro</sup>, this compound achieved very good fitting inside the enzyme&#x02019;s active site with 2 H-bond and 4 hydrophobic interactions with reported key amino acid residues (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="plants-10-00041-f008">Figure 8</xref>) [<xref rid="B90-plants-10-00041" ref-type="bibr">90</xref>].</p><p>In addition to the viral target proteins, 1&#x000df;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate was able to give interesting docking scores with many non-viral targets like adaptor protein 2 associated kinase (AAK1), furin, and cathepsin L (Binding energy = &#x02212;9.1, &#x02212;8.7, and &#x02212;8.1 kcal/mol, respectively).</p><p>AAK1 together with cyclin G-associated kinase (GAK) are considered two key proteins involved in the viral endocytosis process, and hence inhibition of these kinases can prevent the viral entry inside the host cells [<xref rid="B91-plants-10-00041" ref-type="bibr">91</xref>]. On the other hand, furin and cathepsin L are two host-based proteases that are widely distributed in the human lungs. Both enzymes have been reported to be involved in the activation of the viral spike protein (S-protein), which is considered a key step in the viral-host cell attachment and subsequently, viral entry [<xref rid="B92-plants-10-00041" ref-type="bibr">92</xref>]. Thus, targeting these host-based proteins can provide potential anti-COVID-19 therapeutics.</p><p>As illustrated in <xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and (<xref ref-type="fig" rid="plants-10-00041-f009">Figure 9</xref>), 1&#x000df;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11) was able to fit itself inside the AAK1&#x02019;s active site through 5 H-bonds with 5 different amino acid residues together with hydrophobic interactions with another three. Moreover, it accommodated itself inside the active sites of both furin and cathepsin L via the formation of 6 H-bonds. Interestingly, 1&#x000df;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11) has been also found to be a potent inhibitor of HIV-1 reverse transcriptase and DNA polymerase with IC<sub>50</sub> values of 3.7 and 7.4 &#x000b5;M, respectively [<xref rid="B24-plants-10-00041" ref-type="bibr">24</xref>] (<xref ref-type="fig" rid="plants-10-00041-f009">Figure 9</xref>).</p><p>The next top scoring compound was ganoderiol F (14). It is an antitumor triterpene produced by <italic>Ganoderma lucidum</italic>, and its best binding scores were achieved against the viral ADP ribose phosphatase (ARP) and furin (&#x02212;8.0 and &#x02212;8.3 kcal/mol, respectively, <xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref>). ARP was suggested to be involved in the viral protection against the ADP-ribosylation activated by the innate immune system of the host cells, and hence, this protein can be considered a relevant drug target [<xref rid="B93-plants-10-00041" ref-type="bibr">93</xref>,<xref rid="B94-plants-10-00041" ref-type="bibr">94</xref>].</p><p>Ganoderiol F (14) was able to form only three H-bonds inside ARP&#x02019;s active site, however, it interacted with other four amino acid residues through hydrophobic interactions (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="plants-10-00041-f010">Figure 10</xref>).</p><p>Unlike 1&#x000df;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11), ganoderiol F (14) interacted with only four adjacent amino acid residues inside furin&#x02019;s active site (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="plants-10-00041-f010">Figure 10</xref>), however, its hydrophenanthren body was imbedded inside a hydrophobic pocket (LEU-227, VAL-231, and TRP-254).</p><p>Regarding the triterpene suberosol (16), which has been previously isolated from <italic>Polyalthia suberosa</italic> [<xref rid="B50-plants-10-00041" ref-type="bibr">50</xref>], and shown anti-HIV activity, was also able to get high docking scores against 2 targets, AAK1 and GAK (&#x02212;9.0 and &#x02212;8.2 kcal/mol, respectively). Both of these targets are human-based kinases involved in the viral endocytosis regulation [<xref rid="B91-plants-10-00041" ref-type="bibr">91</xref>]. Interestingly, this compound has been shown in vitro antiviral activity against HIV [<xref rid="B50-plants-10-00041" ref-type="bibr">50</xref>]. This compound was able to interact inside both AAK1 and GAKs active site via H-bond (2 interactions) and hydrophobic interactions (three and five interactions, respectively) (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="plants-10-00041-f011">Figure 11</xref>). </p><p>The <italic>G. lucidum</italic>-derived triterpene 20(21)-dehydrolucidenic acid (12) has been shown previously in vitro antiviral activity against both HIV and HCV [<xref rid="B95-plants-10-00041" ref-type="bibr">95</xref>]. In addition, it gave an interesting docking score with the human-based target GAK (Binding energy = &#x02212;8.1 kcal/mol). Being a polyhydroxylated triterpene, 20(21)-dehydrolucidenic acid (12) was able to interact with six amino acid residues inside the enzyme&#x02019;s active site through 9 H-bonds together with two hydrophobic interactions with VAL-54 and LEU-180 (<xref ref-type="fig" rid="plants-10-00041-f011">Figure 11</xref>).</p><p>The last two triterpenes ganodermanondiol (13) and lucidumol A (15) have been also derived from <italic>G. lucidum</italic>, where the former compound has shown inhibitory activity against HIV (IC<sub>50</sub> 90 &#x000b5;m) [<xref rid="B96-plants-10-00041" ref-type="bibr">96</xref>]. Both triterpenes sowed interesting binding energies against the viral target ARP (Binding energy = &#x02212;8.3 and &#x02212;9.6, respectively). Additionally, they interacted with most of the key amino acid residues [<xref rid="B94-plants-10-00041" ref-type="bibr">94</xref>], particularly, lucidumol A (15) (<xref rid="plants-10-00041-t001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="plants-10-00041-f012">Figure 12</xref>).</p><p>Judging from the previous discussion, it can be concluded that the triterpene class of compounds, particularly, the polyhydroxylated ones, can be utilized in the development of multi-target inhibitors against COVID-19. Additionally, four top-scoring compounds out of six have been reported previously from <italic>G. lucidum</italic> indicating that this mushroom could be a valuable source and good starting point for exploring anti-SARS-CoV-2 therapeutics. </p></sec><sec sec-type="conclusions" id="sec6-plants-10-00041"><title>6. Conclusions</title><p>Sterols and triterpenes comprise a huge class of compounds with different biological activities, where mainly they act as anti-cancer, anti-inflammatory, immunomodulatory, and anti-viral. In this review, we were focusing on the antiviral hits, in natural form or derivatized ones that showed potent activities as anti-HIV and showing up their mechanisms of activities that may link these compounds to be a potent hit for the treatment of COVID-19.</p><p>We can be concluded that some compounds can be a good hit for SARS-2, for example, 1&#x003b2;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11) that acting as reverse transcriptase inhibitors, and at the same time it showed a protease inhibitor too; moreover, when the virtual docking of the previously collected compounds against different molecular targets, it was the only compound that got interesting binding scores against the viral main protease (M<sup>pro</sup>) and papain-like protease(PL<sup>pro</sup>) (binding scores of -8.5 and -8.0 kcal/mol, respectively). This compound was able to form four strong hydrogen bonds (&#x0003c; 2.5 &#x000c5;) and with four different amino acid residues inside the M<sup>pro</sup>&#x02019;s active site, three of them have been reported previously as essential ones for the enzyme&#x02019;s inhibition which conformed to its powerful antiviral activity and can be considered a role model for inhibition of COVID-19. In the same manner, Lupeol (12) and Uvaol (14) showed powerful reverse transcriptase inhibitors. Salaspermic acid (13) showed inhibitory activity against HIV via reverse transcriptase and it has replication inhibition activity.</p><p>On the other hand, if we are talking about the replication inhibitors, we can conclude that &#x003b2;-Aescin (19) is the one of choice, as it was reported that it inhibits NF- <italic>&#x00199;</italic>B activation and cytokines production as well as, the inhibition of the replication of SARS-CoV-1 in vitro (IC<sub>50</sub> 6 &#x000b5;M), suggest it may be able to inhibit SARS-CoV-2 too.</p><p>Some of the sulfated sterols e.g halistanol sulfate F (25) and halistanol sulfate G (26) exhibited antiviral activity against HIV-1, this may suggest the importance of the sulfate group in the inhibition of the virus. Alphitolic acid (30) showed an effect quite similar to that of dexamethasone in inhibition of the nuclear factor kappa-B (NF-&#x003ba;B), or suppressing the secretion of pro-inflammatory cytokines such as cytokines suppressor effect of alphitolic acid (30) can help in reducing the severe inflammatory syndrome associated with COVID-19.</p><p>The previous discussion showed that not only the triterpenes are active but also their semi-synthetic derivatives e.g., betulinic acid (31) as the antiviral activity of betulinic acid and its derivatives also have been studied against influenza A, herpes simplex type 1 (HSV-1), and ECHO-6 enterovirus. It has been found that the addition of ureides or the C-28 amide group to betulinic acid increases its anti-HSV-1 activity Moreover, the 3-oxime derivatives of betulonic acid were more active, and this increase the number of active hits and widen their activities.</p><p>One of the most common triterpenes is glycyrrhizin (36) and its metabolites, such as glycyrrhetic acid (GA), reported having the ability to inhibit the cytopathic effect of numerous DNA and RNA viruses such as vaccinia, HSV-1, Newcastle disease, and vesicular stomatitis virus (VSV) in vitro. In vitro studies also showed that glycyrrhizin stopped the secretion of HBV surface antigen (HBsAg) from hepatocytes infected with HBV and also prohibited the viral cytopathic effect and the virus-specific antigen expression in HIV-infected MT-4 cells and inhibited virus replication in cultures of leukocytes from HIV-infected patients and it worth mentioning that, glycyrrhizin can inhibit SARS CoV entry to Vero cells.</p><p>Concerning M<sup>pro</sup> one of the most widespread targets for COVID-19, it was found the quinone-methide triterpenes, pristimererin, tingenone, and iguesterin (38&#x02013;40) have shown potent inhibitory effect against SARS-CoV 3CLpro, this may contribute to the quinone group as through docking study ganoderiol F, that having similar quinone group in the same position showed the next scoring potency to the top 1&#x003b2;-Hydroxyaleuritolic acid 3-p-hydroxybenzoate (11).</p><p>Finally, we would like to highlight the activity of ursolic acid (UA) (42) that was found to have antiviral activity in-vitro against rotavirus infections and it inhibited rotavirus replication, this may suggest its ability to inhibit some of coronaviruses effects when attacking the GIT in similar mechanisms.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Deraya University for supporting the work.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, N.H.S., K.A.Y. and A.M.S.; methodology, N.H.S., K.A.Y. and A.M.S.; software, N.H.S., K.A.Y. and A.M.S.; validation, L.B., T.O., H.M.H. and U.R.A.; formal analysis, N.H.S., K.A.Y., A.M.S., L.B., T.O., H.M.H. and U.R.A.; investigation, N.H.S., K.A.Y., A.M.S., L.B., T.O., H.M.H. and U.R.A.; resources, N.H.S., K.A.Y., A.M.S., L.B., T.O., H.M.H. and U.R.A.; data curation, L.B., T.O., H.M.H. and U.R.A.; writing&#x02014;original draft preparation, N.H.S., K.A.Y. and A.M.S.; writing&#x02014;review and editing, N.H.S., K.A.Y. and A.M.S.; visualization, L.B., T.O., H.M.H. and U.R.A.; supervision, L.B., T.O., H.M.H. and U.R.A.; project administration, L.B., T.O., H.M.H. and U.R.A. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-plants-10-00041"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name><name><surname>Keyzers</surname><given-names>R.A.</given-names></name><name><surname>Munro</surname><given-names>M.H.</given-names></name><name><surname>Prinsep</surname><given-names>M.R.</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2013</year><volume>30</volume><fpage>237</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1039/C2NP20112G</pub-id><?supplied-pmid 23263727?><pub-id pub-id-type="pmid">23263727</pub-id></element-citation></ref><ref id="B2-plants-10-00041"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salendra</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Pang</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Long</surname><given-names>J.</given-names></name><name><surname>Liao</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Cytotoxicity of polyketides and steroids isolated from the sponge-associated fungus <italic>Penicillium citrinum</italic> SCSIO 41017</article-title><source>Nat. Prod. Res.</source><year>2019</year><volume>1478&#x02013;6419</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/14786419.2019.1610757</pub-id><?supplied-pmid 31148464?><pub-id pub-id-type="pmid">31148464</pub-id></element-citation></ref><ref id="B3-plants-10-00041"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vil</surname><given-names>V.A.</given-names></name><name><surname>Terent&#x02019;ev</surname><given-names>A.O.</given-names></name><name><surname>Savidov</surname><given-names>N.</given-names></name><name><surname>Gloriozova</surname><given-names>T.A.</given-names></name><name><surname>Poroikov</surname><given-names>V.V.</given-names></name><name><surname>Pounina</surname><given-names>T.A.</given-names></name><name><surname>Dembitsky</surname><given-names>V.M.</given-names></name></person-group><article-title>Hydroperoxy steroids and triterpenoids derived from plant and fungi: Origin, structures, and biological activities</article-title><source>J. Steroid Biochem. Mol. Biol.</source><year>2019</year><volume>190</volume><fpage>76</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.jsbmb.2019.03.020</pub-id><?supplied-pmid 30923015?><pub-id pub-id-type="pmid">30923015</pub-id></element-citation></ref><ref id="B4-plants-10-00041"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Withering</surname><given-names>W.</given-names></name></person-group><source>An Account of the Foxglove, and Some of Its Medical Uses</source><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc><year>2014</year></element-citation></ref><ref id="B5-plants-10-00041"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krim</surname><given-names>S.R.</given-names></name><name><surname>Vivo</surname><given-names>R.P.</given-names></name><name><surname>Perez</surname><given-names>J.</given-names></name><name><surname>Inklab</surname><given-names>M.</given-names></name><name><surname>Tenner Jr</surname><given-names>T.</given-names></name><name><surname>Hodgson</surname><given-names>J.</given-names></name></person-group><article-title>Digoxin: Current use and approach to toxicity</article-title><source>Am. J. Med Sci.</source><year>2008</year><volume>336</volume><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1097/MAJ.0b013e318176b94d</pub-id><?supplied-pmid 19011400?><pub-id pub-id-type="pmid">19011400</pub-id></element-citation></ref><ref id="B6-plants-10-00041"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>A.</given-names></name><name><surname>Russell</surname><given-names>A.</given-names></name></person-group><article-title>Mupirocin, fusidic acid and bacitracin: Activity, action and clinical uses of three topical antibiotics</article-title><source>Vet. Dermatol.</source><year>1999</year><volume>10</volume><fpage>225</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1046/j.1365-3164.1999.00185.x</pub-id></element-citation></ref><ref id="B7-plants-10-00041"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>R.C.</given-names></name><name><surname>da Silva</surname><given-names>T.P.</given-names></name><name><surname>Campello</surname><given-names>R.S.</given-names></name><name><surname>Machado</surname><given-names>U.F.</given-names></name></person-group><article-title>Carbenoxolone enhances peripheral insulin sensitivity and GLUT4 expression in skeletal muscle of obese rats: Potential participation of UBC9 protein</article-title><source>Life Sci.</source><year>2019</year><volume>229</volume><fpage>157</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2019.05.017</pub-id><pub-id pub-id-type="pmid">31077719</pub-id></element-citation></ref><ref id="B8-plants-10-00041"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>R.</given-names></name><name><surname>Hill</surname><given-names>I.</given-names></name><name><surname>Hutton</surname><given-names>C.</given-names></name></person-group><article-title>Treatment of gastric ulcer with carbenoxolone sodium and oestrogens</article-title><source>Gut</source><year>1965</year><volume>6</volume><fpage>19</fpage><pub-id pub-id-type="doi">10.1136/gut.6.1.19</pub-id><pub-id pub-id-type="pmid">14259418</pub-id></element-citation></ref><ref id="B9-plants-10-00041"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ming</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Synergistic effects of &#x003b2;-aescin and 5-fluorouracil in human hepatocellular carcinoma SMMC-7721 cells</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><fpage>575</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.12.009</pub-id><pub-id pub-id-type="pmid">20106644</pub-id></element-citation></ref><ref id="B10-plants-10-00041"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamsabadipour</surname><given-names>S.</given-names></name><name><surname>Ghanadian</surname><given-names>M.</given-names></name><name><surname>Saeedi</surname><given-names>H.</given-names></name><name><surname>Rahimnejad</surname><given-names>M.R.</given-names></name><name><surname>Mohammadi-Kamalabadi</surname><given-names>M.</given-names></name><name><surname>Ayatollahi</surname><given-names>S.M.</given-names></name><name><surname>Salimzadeh</surname><given-names>L.</given-names></name></person-group><article-title>Triterpenes and steroids from Euphorbia denticulata Lam. with anti-Herpes symplex virus activity</article-title><source>Iran. J. Pharm. Res.</source><year>2013</year><volume>12</volume><fpage>759</fpage><pub-id pub-id-type="pmid">24523756</pub-id></element-citation></ref><ref id="B11-plants-10-00041"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W.B.</given-names></name><name><surname>Tao</surname><given-names>J.Y.</given-names></name><name><surname>Xu</surname><given-names>H.M.</given-names></name><name><surname>Chen</surname><given-names>K.L.</given-names></name><name><surname>Zeng</surname><given-names>G.Z.</given-names></name><name><surname>Ji</surname><given-names>C.J.</given-names></name><name><surname>Zhang</surname><given-names>Y.M.</given-names></name><name><surname>Tan</surname><given-names>N.H.</given-names></name></person-group><article-title>Three new antiviral triterpenes from Aster tataricus</article-title><source>Z. Nat. B</source><year>2010</year><volume>65</volume><fpage>1393</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1515/znb-2010-1116</pub-id></element-citation></ref><ref id="B12-plants-10-00041"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezanka</surname><given-names>T.</given-names></name><name><surname>Siristova</surname><given-names>L.</given-names></name><name><surname>Sigler</surname><given-names>K.</given-names></name></person-group><article-title>Sterols and triterpenoids with antiviral activity</article-title><source>Anti Infect. Agents Med. Chem.</source><year>2009</year><volume>8</volume><fpage>193</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.2174/187152109788680207</pub-id></element-citation></ref><ref id="B13-plants-10-00041"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Buckingham</surname><given-names>J.</given-names></name></person-group><source>Dictionary of Natural Products</source><publisher-name>Chapman and Hall</publisher-name><publisher-loc>London, UK</publisher-loc><year>1994</year></element-citation></ref><ref id="B14-plants-10-00041"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trott</surname><given-names>O.</given-names></name><name><surname>Olson</surname><given-names>A.J.</given-names></name></person-group><article-title>AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title><source>J. Comput. Chem.</source><year>2010</year><volume>31</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id><?supplied-pmid 19499576?><pub-id pub-id-type="pmid">19499576</pub-id></element-citation></ref><ref id="B15-plants-10-00041"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayed</surname><given-names>A.M.</given-names></name><name><surname>Alhadrami</surname><given-names>H.A.</given-names></name><name><surname>El-Gendy</surname><given-names>A.O.</given-names></name><name><surname>Shamikh</surname><given-names>Y.I.</given-names></name><name><surname>Belbahri</surname><given-names>L.</given-names></name><name><surname>Hassan</surname><given-names>H.M.</given-names></name><name><surname>Abdelmohsen</surname><given-names>U.R.</given-names></name><name><surname>Rateb</surname><given-names>M.E.</given-names></name></person-group><article-title>Microbial natural products as potential inhibitors of SARS-CoV-2 main protease (Mpro)</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>970</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8070970</pub-id><?supplied-pmid 32610445?><pub-id pub-id-type="pmid">32610445</pub-id></element-citation></ref><ref id="B16-plants-10-00041"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lill</surname><given-names>M.A.</given-names></name><name><surname>Danielson</surname><given-names>M.L.</given-names></name></person-group><article-title>Computer-aided drug design platform using PyMOL</article-title><source>J. Comput. Aided Mol. Des.</source><year>2011</year><volume>25</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1007/s10822-010-9395-8</pub-id><pub-id pub-id-type="pmid">21053052</pub-id></element-citation></ref><ref id="B17-plants-10-00041"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akihisa</surname><given-names>T.</given-names></name><name><surname>Ogihara</surname><given-names>J.</given-names></name><name><surname>Kato</surname><given-names>J.</given-names></name><name><surname>Yasukawa</surname><given-names>K.</given-names></name><name><surname>Ukiya</surname><given-names>M.</given-names></name><name><surname>Yamanouchi</surname><given-names>S.</given-names></name><name><surname>Oishi</surname><given-names>K.</given-names></name></person-group><article-title>Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase</article-title><source>Lipids</source><year>2001</year><volume>36</volume><fpage>507</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1007/s11745-001-0750-4</pub-id><pub-id pub-id-type="pmid">11432464</pub-id></element-citation></ref><ref id="B18-plants-10-00041"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.-K.</given-names></name><name><surname>Van Ta</surname><given-names>Q.</given-names></name></person-group><article-title>Chapter 17&#x02014;Bioactive Sterols from Marine Resources and Their Potential Benefits for Human Health</article-title><source>Advances in Food and Nutrition Research</source><person-group person-group-type="editor"><name><surname>Kim</surname><given-names>S.-K.</given-names></name></person-group><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2012</year><volume>Volume 65</volume><fpage>261</fpage><lpage>268</lpage></element-citation></ref><ref id="B19-plants-10-00041"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Tian</surname><given-names>W.</given-names></name></person-group><article-title>A concise synthesis of the steroidal core of clathsterol</article-title><source>Tetrahedron Lett.</source><year>2010</year><volume>51</volume><fpage>3890</fpage><lpage>3892</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2010.05.072</pub-id></element-citation></ref><ref id="B20-plants-10-00041"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quint&#x000e3;o</surname><given-names>N.L.M.</given-names></name><name><surname>Rocha</surname><given-names>L.W.</given-names></name><name><surname>Silva</surname><given-names>G.F.</given-names></name><name><surname>Reichert</surname><given-names>S.</given-names></name><name><surname>Claudino</surname><given-names>V.D.</given-names></name><name><surname>Lucinda-Silva</surname><given-names>R.M.</given-names></name><name><surname>Malheiros</surname><given-names>A.</given-names></name><name><surname>Souza</surname><given-names>M.M.D.</given-names></name><name><surname>Bell&#x000e9; Bresolin</surname><given-names>T.M.</given-names></name><name><surname>Machado</surname><given-names>M.D.S.</given-names></name></person-group><article-title>Contribution of &#x003b1;, &#x003b2;-Amyrenone to the Anti-Inflammatory and Antihypersensitivity Effects of <italic>Aleurites moluccana</italic> (L.) Willd</article-title><source>Biomed Res. Int.</source><year>2014</year><volume>2014</volume><fpage>636839</fpage><pub-id pub-id-type="pmid">25386561</pub-id></element-citation></ref><ref id="B21-plants-10-00041"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>S.</given-names></name><name><surname>Uno</surname><given-names>C.</given-names></name><name><surname>Akimoto</surname><given-names>M.</given-names></name><name><surname>Tabata</surname><given-names>M.</given-names></name><name><surname>Honda</surname><given-names>C.</given-names></name><name><surname>Kamisako</surname><given-names>W.</given-names></name></person-group><article-title>Anti-allergic effect of bryonolic acid from Luffa cylindrica cell suspension cultures</article-title><source>Planta Med.</source><year>1991</year><volume>57</volume><fpage>527</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1055/s-2006-960199</pub-id><pub-id pub-id-type="pmid">1818343</pub-id></element-citation></ref><ref id="B22-plants-10-00041"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lertphadungkit</surname><given-names>P.</given-names></name><name><surname>Suksiriworapong</surname><given-names>J.</given-names></name><name><surname>Satitpatipan</surname><given-names>V.</given-names></name><name><surname>Sirikantaramas</surname><given-names>S.</given-names></name><name><surname>Wongrakpanich</surname><given-names>A.</given-names></name><name><surname>Bunsupa</surname><given-names>S.</given-names></name></person-group><article-title>Enhanced Production of Bryonolic Acid in <italic>Trichosanthes cucumerina</italic> L. (Thai Cultivar) Cell Cultures by Elicitors and Their Biological Activities</article-title><source>Plants</source><year>2020</year><volume>9</volume><elocation-id>709</elocation-id><pub-id pub-id-type="doi">10.3390/plants9060709</pub-id></element-citation></ref><ref id="B23-plants-10-00041"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akihisa</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Tamura</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>Y.</given-names></name><name><surname>Iida</surname><given-names>T.</given-names></name><name><surname>Nambara</surname><given-names>T.</given-names></name><name><surname>Chang</surname><given-names>F.C.</given-names></name></person-group><article-title>Triterpenoid Ketones from Lingnania chungii MoClure: Arborinone, friedelin and glutinone</article-title><source>Chem. Pharm. Bull.</source><year>1992</year><volume>40</volume><fpage>789</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1248/cpb.40.789</pub-id></element-citation></ref><ref id="B24-plants-10-00041"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pengsuparp</surname><given-names>T.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Constant</surname><given-names>H.</given-names></name><name><surname>Fong</surname><given-names>H.H.</given-names></name><name><surname>Lin</surname><given-names>L.-Z.</given-names></name><name><surname>Kinghorn</surname><given-names>A.D.</given-names></name><name><surname>Pezzuto</surname><given-names>J.M.</given-names></name><name><surname>Cordell</surname><given-names>G.A.</given-names></name><name><surname>Ingolfsd&#x000f6;ttir</surname><given-names>K.</given-names></name><name><surname>Wagner</surname><given-names>H.</given-names></name></person-group><article-title>Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase</article-title><source>J. Nat. Prod.</source><year>1995</year><volume>58</volume><fpage>1024</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1021/np50121a006</pub-id><?supplied-pmid 7561895?><pub-id pub-id-type="pmid">7561895</pub-id></element-citation></ref><ref id="B25-plants-10-00041"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Rehaily</surname><given-names>A.J.</given-names></name><name><surname>El-Tahir</surname><given-names>K.E.</given-names></name><name><surname>Mossa</surname><given-names>J.S.</given-names></name><name><surname>Rafatullah</surname><given-names>S.</given-names></name></person-group><article-title>Pharmacological studies of various extracts and the major constituent, lupeol, obtained from hexane extract of Teclea nobilis in rodents</article-title><source>Nat. Prod. Sci.</source><year>2001</year><volume>7</volume><fpage>76</fpage><lpage>82</lpage></element-citation></ref><ref id="B26-plants-10-00041"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>A.</given-names></name><name><surname>Alvarez</surname><given-names>A.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>M.D.</given-names></name><name><surname>S&#x000e1;enz</surname><given-names>M.T.</given-names></name></person-group><article-title>Anti-inflammatory effect of Pimenta racemosa var. ozua and isolation of the triterpene lupeol</article-title><source>Il Farm.</source><year>2001</year><volume>56</volume><fpage>335</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/S0014-827X(01)01080-1</pub-id></element-citation></ref><ref id="B27-plants-10-00041"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>M.A.</given-names></name><name><surname>de las Heras</surname><given-names>B.</given-names></name><name><surname>Garcia</surname><given-names>M.D.</given-names></name><name><surname>S&#x000e1;enz</surname><given-names>M.T.</given-names></name><name><surname>Villar</surname><given-names>A.</given-names></name></person-group><article-title>New insights into the mechanism of action of the anti-inflammatory triterpene lupeol</article-title><source>J. Pharm. Pharmacol.</source><year>2001</year><volume>53</volume><fpage>1533</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1211/0022357011777909</pub-id><pub-id pub-id-type="pmid">11732756</pub-id></element-citation></ref><ref id="B28-plants-10-00041"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>P.K.</given-names></name><name><surname>Bhui</surname><given-names>K.</given-names></name><name><surname>Shukla</surname><given-names>Y.</given-names></name></person-group><article-title>Lupeol: Connotations for chemoprevention</article-title><source>Cancer Lett.</source><year>2008</year><volume>263</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2008.01.047</pub-id><pub-id pub-id-type="pmid">18359153</pub-id></element-citation></ref><ref id="B29-plants-10-00041"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhahar</surname><given-names>V.</given-names></name><name><surname>Kumar</surname><given-names>S.A.</given-names></name><name><surname>Varalakshmi</surname><given-names>P.</given-names></name><name><surname>Sujatha</surname><given-names>V.</given-names></name></person-group><article-title>Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage</article-title><source>Mol. Cell. Biochem.</source><year>2008</year><volume>317</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1007/s11010-008-9786-5</pub-id><pub-id pub-id-type="pmid">18563536</pub-id></element-citation></ref><ref id="B30-plants-10-00041"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhahar</surname><given-names>V.</given-names></name><name><surname>Veena</surname><given-names>C.K.</given-names></name><name><surname>Varalakshmi</surname><given-names>P.</given-names></name></person-group><article-title>Antiurolithic effect of lupeol and lupeol linoleate in experimental hyperoxaluria</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>1509</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1021/np0703141</pub-id><pub-id pub-id-type="pmid">18717586</pub-id></element-citation></ref><ref id="B31-plants-10-00041"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddique</surname><given-names>H.R.</given-names></name><name><surname>Saleem</surname><given-names>M.</given-names></name></person-group><article-title>Beneficial health effects of lupeol triterpene: A review of preclinical studies</article-title><source>Life Sci.</source><year>2011</year><volume>88</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2010.11.020</pub-id><pub-id pub-id-type="pmid">21118697</pub-id></element-citation></ref><ref id="B32-plants-10-00041"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P.</given-names></name><name><surname>McAuley</surname><given-names>D.F.</given-names></name><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Tattersall</surname><given-names>R.S.</given-names></name><name><surname>Manson</surname><given-names>J.J.</given-names></name><name><surname>Collaboration</surname><given-names>H.A.S.</given-names></name></person-group><article-title>COVID-19: Consider cytokine storm syndromes and immunosuppression</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>1033</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30628-0</pub-id><pub-id pub-id-type="pmid">32192578</pub-id></element-citation></ref><ref id="B33-plants-10-00041"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>R.</given-names></name></person-group><article-title>Antiviral activity of compounds isolated from plants</article-title><source>Pharm. Biol.</source><year>2003</year><volume>41</volume><fpage>107</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1076/phbi.41.2.107.14240</pub-id></element-citation></ref><ref id="B34-plants-10-00041"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khwaza</surname><given-names>V.</given-names></name><name><surname>Oyedeji</surname><given-names>O.O.</given-names></name><name><surname>Aderibigbe</surname><given-names>B.A.</given-names></name></person-group><article-title>Antiviral activities of oleanolic acid and its analogues</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2300</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23092300</pub-id><?supplied-pmid 30205592?><pub-id pub-id-type="pmid">30205592</pub-id></element-citation></ref><ref id="B35-plants-10-00041"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzubak</surname><given-names>P.</given-names></name><name><surname>Hajduch</surname><given-names>M.</given-names></name><name><surname>Vydra</surname><given-names>D.</given-names></name><name><surname>Hustova</surname><given-names>A.</given-names></name><name><surname>Kvasnica</surname><given-names>M.</given-names></name><name><surname>Biedermann</surname><given-names>D.</given-names></name><name><surname>Markova</surname><given-names>L.</given-names></name><name><surname>Urban</surname><given-names>M.</given-names></name><name><surname>Sarek</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacological activities of natural triterpenoids and their therapeutic implications</article-title><source>Nat. Prod. Rep.</source><year>2006</year><volume>23</volume><fpage>394</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1039/b515312n</pub-id><?supplied-pmid 16741586?><pub-id pub-id-type="pmid">16741586</pub-id></element-citation></ref><ref id="B36-plants-10-00041"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayed</surname><given-names>A.M.</given-names></name><name><surname>Khattab</surname><given-names>A.R.</given-names></name><name><surname>AboulMagd</surname><given-names>A.M.</given-names></name><name><surname>Hassan</surname><given-names>H.M.</given-names></name><name><surname>Rateb</surname><given-names>M.E.</given-names></name><name><surname>Zaid</surname><given-names>H.</given-names></name><name><surname>Abdelmohsen</surname><given-names>U.R.</given-names></name></person-group><article-title>Nature as a treasure trove of potential anti-SARS-CoV drug leads: A structural/mechanistic rationale</article-title><source>RSC Adv.</source><year>2020</year><volume>10</volume><fpage>19790</fpage><lpage>19802</lpage><pub-id pub-id-type="doi">10.1039/D0RA04199H</pub-id></element-citation></ref><ref id="B37-plants-10-00041"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suwannarach</surname><given-names>N.</given-names></name><name><surname>Kumla</surname><given-names>J.</given-names></name><name><surname>Sujarit</surname><given-names>K.</given-names></name><name><surname>Pattananandecha</surname><given-names>T.</given-names></name><name><surname>Saenjum</surname><given-names>C.</given-names></name><name><surname>Lumyong</surname><given-names>S.</given-names></name></person-group><article-title>Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>1800</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25081800</pub-id><?supplied-pmid 32295300?><pub-id pub-id-type="pmid">32295300</pub-id></element-citation></ref><ref id="B38-plants-10-00041"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Dine</surname><given-names>R.S.</given-names></name><name><surname>El Halawany</surname><given-names>A.M.</given-names></name><name><surname>Ma</surname><given-names>C.-M.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name></person-group><article-title>Anti-HIV-1 protease activity of lanostane triterpenes from the vietnamese mushroom Ganoderma colossum</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>1022</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.1021/np8001139</pub-id><?supplied-pmid 18547117?><pub-id pub-id-type="pmid">18547117</pub-id></element-citation></ref><ref id="B39-plants-10-00041"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirtori</surname><given-names>C.R.</given-names></name></person-group><article-title>Aescin: Pharmacology, pharmacokinetics and therapeutic profile</article-title><source>Pharmacol. Res.</source><year>2001</year><volume>44</volume><fpage>183</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1006/phrs.2001.0847</pub-id><?supplied-pmid 11529685?><pub-id pub-id-type="pmid">11529685</pub-id></element-citation></ref><ref id="B40-plants-10-00041"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittler</surname><given-names>M.H.</given-names></name><name><surname>Ernst</surname><given-names>E.</given-names></name></person-group><article-title>Horse chestnut seed extract for chronic venous insufficiency</article-title><source>Cochrane Database Syst. Rev.</source><year>2012</year><fpage>1465</fpage><lpage>1858</lpage><pub-id pub-id-type="doi">10.1002/14651858.CD003230.pub4</pub-id></element-citation></ref><ref id="B41-plants-10-00041"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domanski</surname><given-names>D.</given-names></name><name><surname>Zegrocka-Stendel</surname><given-names>O.</given-names></name><name><surname>Perzanowska</surname><given-names>A.</given-names></name><name><surname>Dutkiewicz</surname><given-names>M.</given-names></name><name><surname>Kowalewska</surname><given-names>M.</given-names></name><name><surname>Grabowska</surname><given-names>I.</given-names></name><name><surname>Maciejko</surname><given-names>D.</given-names></name><name><surname>Fogtman</surname><given-names>A.</given-names></name><name><surname>Dadlez</surname><given-names>M.</given-names></name><name><surname>Koziak</surname><given-names>K.</given-names></name></person-group><article-title>Molecular mechanism for cellular response to &#x003b2;-escin and its therapeutic implications</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0164365</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0164365</pub-id><pub-id pub-id-type="pmid">27727329</pub-id></element-citation></ref><ref id="B42-plants-10-00041"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>F.</given-names></name><name><surname>Jiang</surname><given-names>N.</given-names></name><name><surname>Fan</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>F.</given-names></name></person-group><article-title>Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><fpage>272</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2010.08.013</pub-id><pub-id pub-id-type="pmid">20850956</pub-id></element-citation></ref><ref id="B43-plants-10-00041"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanya</surname><given-names>S.B.</given-names></name><name><surname>Venkataraman</surname><given-names>B.</given-names></name><name><surname>Meeran</surname><given-names>M.F.N.</given-names></name><name><surname>Goyal</surname><given-names>S.N.</given-names></name><name><surname>Patil</surname><given-names>C.R.</given-names></name><name><surname>Ojha</surname><given-names>S.</given-names></name></person-group><article-title>Therapeutic potential of plants and plant derived phytochemicals against acetaminophen-induced liver injury</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><elocation-id>3776</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19123776</pub-id></element-citation></ref><ref id="B44-plants-10-00041"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashiwada</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.-K.</given-names></name><name><surname>Nagao</surname><given-names>T.</given-names></name><name><surname>Kitanaka</surname><given-names>S.</given-names></name><name><surname>Yasuda</surname><given-names>I.</given-names></name><name><surname>Fujioka</surname><given-names>T.</given-names></name><name><surname>Yamagishi</surname><given-names>T.</given-names></name><name><surname>Cosentino</surname><given-names>L.M.</given-names></name><name><surname>Kozuka</surname><given-names>M.</given-names></name><name><surname>Okabe</surname><given-names>H.</given-names></name></person-group><article-title>Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids</article-title><source>J. Nat. Prod.</source><year>1998</year><volume>61</volume><fpage>1090</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1021/np9800710</pub-id><?supplied-pmid 9748372?><pub-id pub-id-type="pmid">9748372</pub-id></element-citation></ref><ref id="B45-plants-10-00041"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D.-F.</given-names></name><name><surname>Zhang</surname><given-names>S.-X.</given-names></name><name><surname>Wang</surname><given-names>H.-K.</given-names></name><name><surname>Zhang</surname><given-names>S.-Y.</given-names></name><name><surname>Sun</surname><given-names>Q.-Z.</given-names></name><name><surname>Cosentino</surname><given-names>L.M.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name></person-group><article-title>Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba</article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>94</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1021/np980291d</pub-id><?supplied-pmid 9917290?><pub-id pub-id-type="pmid">9917290</pub-id></element-citation></ref><ref id="B46-plants-10-00041"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oprean</surname><given-names>C.</given-names></name><name><surname>Mioc</surname><given-names>M.</given-names></name><name><surname>Cs&#x000e1;nyi</surname><given-names>E.</given-names></name><name><surname>Ambrus</surname><given-names>R.</given-names></name><name><surname>Bojin</surname><given-names>F.</given-names></name><name><surname>Tatu</surname><given-names>C.</given-names></name><name><surname>Cristea</surname><given-names>M.</given-names></name><name><surname>Ivan</surname><given-names>A.</given-names></name><name><surname>Danciu</surname><given-names>C.</given-names></name><name><surname>Dehelean</surname><given-names>C.</given-names></name></person-group><article-title>Improvement of ursolic and oleanolic acids&#x02019; antitumor activity by complexation with hydrophilic cyclodextrins</article-title><source>Biomed. Pharmacother.</source><year>2016</year><volume>83</volume><fpage>1095</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.08.030</pub-id><?supplied-pmid 27551755?><pub-id pub-id-type="pmid">27551755</pub-id></element-citation></ref><ref id="B47-plants-10-00041"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Bi</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name></person-group><article-title>Low dose of oleanolic acid protects against lithocholic acid&#x02013;induced cholestasis in mice: Potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins</article-title><source>Drug Metab. Dispos.</source><year>2014</year><volume>42</volume><fpage>844</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1124/dmd.113.056549</pub-id><pub-id pub-id-type="pmid">24510383</pub-id></element-citation></ref><ref id="B48-plants-10-00041"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jesus</surname><given-names>J.A.</given-names></name><name><surname>Lago</surname><given-names>J.H.G.</given-names></name><name><surname>Laurenti</surname><given-names>M.D.</given-names></name><name><surname>Yamamoto</surname><given-names>E.S.</given-names></name><name><surname>Passero</surname><given-names>L.F.D.</given-names></name></person-group><article-title>Antimicrobial activity of oleanolic and ursolic acids: An update</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2015</year><volume>2015</volume><fpage>620472</fpage><pub-id pub-id-type="doi">10.1155/2015/620472</pub-id></element-citation></ref><ref id="B49-plants-10-00041"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.-M.</given-names></name><name><surname>Shen</surname><given-names>J.-K.</given-names></name><name><surname>Wang</surname><given-names>H.-K.</given-names></name><name><surname>Cosentino</surname><given-names>L.M.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name></person-group><article-title>Synthesis and anti-HIV activity of oleanolic acid derivatives</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2001</year><volume>11</volume><fpage>3115</fpage><lpage>3118</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(01)00647-3</pub-id><pub-id pub-id-type="pmid">11720855</pub-id></element-citation></ref><ref id="B50-plants-10-00041"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.-Y.</given-names></name><name><surname>Sun</surname><given-names>N.-J.</given-names></name><name><surname>Kashiwada</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Snider</surname><given-names>J.V.</given-names></name><name><surname>Cosentino</surname><given-names>L.M.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name></person-group><article-title>Anti-AIDS agents, 9. Suberosol, a new C31 lanostane-type triterpene and anti-HIV principle from Polyalthia suberosa</article-title><source>J. Nat. Prod.</source><year>1993</year><volume>56</volume><fpage>1130</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1021/np50097a017</pub-id><pub-id pub-id-type="pmid">8377018</pub-id></element-citation></ref><ref id="B51-plants-10-00041"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bifulco</surname><given-names>G.</given-names></name><name><surname>Bruno</surname><given-names>I.</given-names></name><name><surname>Minale</surname><given-names>L.</given-names></name><name><surname>Riccio</surname><given-names>R.</given-names></name></person-group><article-title>Novel HIV-inhibitory halistanol sulfates F-H from a marine sponge, Pseudoaxinissa digitata</article-title><source>J. Nat. Prod.</source><year>1994</year><volume>57</volume><fpage>164</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1021/np50103a026</pub-id><pub-id pub-id-type="pmid">8158159</pub-id></element-citation></ref><ref id="B52-plants-10-00041"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koehn</surname><given-names>F.E.</given-names></name><name><surname>Gunasekera</surname><given-names>M.</given-names></name><name><surname>Cross</surname><given-names>S.S.</given-names></name></person-group><article-title>New antiviral sterol disulfate ortho esters from the marine sponge Petrosia weinbergi</article-title><source>J. Org. Chem.</source><year>1991</year><volume>56</volume><fpage>1322</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1021/jo00003a080</pub-id></element-citation></ref><ref id="B53-plants-10-00041"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name></person-group><article-title>Study on chemical composition, anti-inflammatory and anti-microbial activities of extracts from Chinese pear fruit (<italic>Pyrus bretschneideri</italic> Rehd.)</article-title><source>Food Chem. Toxicol.</source><year>2012</year><volume>50</volume><fpage>3673</fpage><lpage>3679</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2012.07.019</pub-id><pub-id pub-id-type="pmid">22824088</pub-id></element-citation></ref><ref id="B54-plants-10-00041"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghaddam</surname><given-names>M.G.</given-names></name><name><surname>Faujan Bin</surname><given-names>H.</given-names></name><name><surname>Ahmad</surname><given-names>F.H.</given-names></name><name><surname>Kermani</surname><given-names>A.S.</given-names></name></person-group><article-title>Biological Activity of Betulinic Acid: A Review</article-title><source>Pharmacol. Pharm.</source><year>2012</year><volume>3</volume><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.4236/pp.2012.32018</pub-id></element-citation></ref><ref id="B55-plants-10-00041"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Wild</surname><given-names>C.T.</given-names></name><name><surname>Martin</surname><given-names>D.E.</given-names></name><name><surname>Morris-Natschke</surname><given-names>S.L.</given-names></name><name><surname>Chen</surname><given-names>C.-H.</given-names></name><name><surname>Allaway</surname><given-names>G.P.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name></person-group><article-title>The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV</article-title><source>Expert Opin. Investig. Drugs</source><year>2005</year><volume>14</volume><fpage>681</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1517/13543784.14.6.681</pub-id><?supplied-pmid 16004596?><pub-id pub-id-type="pmid">16004596</pub-id></element-citation></ref><ref id="B56-plants-10-00041"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paduch</surname><given-names>R.</given-names></name><name><surname>Kandefer-Szerszen</surname><given-names>M.</given-names></name></person-group><article-title>Antitumor and antiviral activity of pentacyclic triterpenes</article-title><source>Mini Rev. Org. Chem.</source><year>2014</year><volume>11</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.2174/1570193X1103140915105240</pub-id></element-citation></ref><ref id="B57-plants-10-00041"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soler</surname><given-names>F.</given-names></name><name><surname>Poujade</surname><given-names>C.</given-names></name><name><surname>Evers</surname><given-names>M.</given-names></name><name><surname>Carry</surname><given-names>J.-C.</given-names></name><name><surname>H&#x000e9;nin</surname><given-names>Y.</given-names></name><name><surname>Bousseau</surname><given-names>A.</given-names></name><name><surname>Huet</surname><given-names>T.</given-names></name><name><surname>Pauwels</surname><given-names>R.</given-names></name><name><surname>De Clercq</surname><given-names>E.</given-names></name><name><surname>Mayaux</surname><given-names>J.-F.</given-names></name></person-group><article-title>Betulinic acid derivatives: A new class of specific inhibitors of human immunodeficiency virus type 1 entry</article-title><source>J. Med. Chem.</source><year>1996</year><volume>39</volume><fpage>1069</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1021/jm950669u</pub-id><pub-id pub-id-type="pmid">8676342</pub-id></element-citation></ref><ref id="B58-plants-10-00041"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>K.</given-names></name><name><surname>Morris-Natschke</surname><given-names>S.L.</given-names></name><name><surname>Lee</surname><given-names>K.H.</given-names></name></person-group><article-title>HIV entry inhibitors and their potential in HIV therapy</article-title><source>Med. Res. Rev.</source><year>2009</year><volume>29</volume><fpage>369</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1002/med.20138</pub-id><pub-id pub-id-type="pmid">18720513</pub-id></element-citation></ref><ref id="B59-plants-10-00041"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohjala</surname><given-names>L.</given-names></name><name><surname>Alakurtti</surname><given-names>S.</given-names></name><name><surname>Ahola</surname><given-names>T.</given-names></name><name><surname>Yli-Kauhaluoma</surname><given-names>J.</given-names></name><name><surname>Tammela</surname><given-names>P.</given-names></name></person-group><article-title>Betulin-derived compounds as inhibitors of alphavirus replication</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>1917</fpage><lpage>1926</lpage><pub-id pub-id-type="doi">10.1021/np9003245</pub-id><pub-id pub-id-type="pmid">19839605</pub-id></element-citation></ref><ref id="B60-plants-10-00041"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlova</surname><given-names>N.</given-names></name><name><surname>Savinova</surname><given-names>O.</given-names></name><name><surname>Nikolaeva</surname><given-names>S.</given-names></name><name><surname>Boreko</surname><given-names>E.</given-names></name><name><surname>Flekhter</surname><given-names>O.</given-names></name></person-group><article-title>Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses</article-title><source>Fitoterapia</source><year>2003</year><volume>74</volume><fpage>489</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(03)00123-0</pub-id><pub-id pub-id-type="pmid">12837369</pub-id></element-citation></ref><ref id="B61-plants-10-00041"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flekhter</surname><given-names>O.B.</given-names></name><name><surname>Karachurina</surname><given-names>L.T.</given-names></name><name><surname>Nigmatullina</surname><given-names>L.R.</given-names></name><name><surname>Sapozhnikova</surname><given-names>T.A.</given-names></name><name><surname>Baltina</surname><given-names>L.A.</given-names></name><name><surname>Zarudii</surname><given-names>F.S.</given-names></name><name><surname>Galin</surname><given-names>F.Z.</given-names></name><name><surname>Spirikhin</surname><given-names>L.V.</given-names></name><name><surname>Tolstikov</surname><given-names>G.A.</given-names></name><name><surname>Plyasunova</surname><given-names>O.A.</given-names></name></person-group><article-title>Synthesis and pharmacological activity of betulin dinicotinate</article-title><source>Russ. J. Bioorg. Chem.</source><year>2002</year><volume>28</volume><fpage>494</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1023/A:1021297600187</pub-id></element-citation></ref><ref id="B62-plants-10-00041"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltina</surname><given-names>L.A.</given-names></name><name><surname>Flekhter</surname><given-names>O.B.</given-names></name><name><surname>Nigmatullina</surname><given-names>L.R.</given-names></name><name><surname>Boreko</surname><given-names>E.I.</given-names></name><name><surname>Pavlova</surname><given-names>N.I.</given-names></name><name><surname>Nikolaeve</surname><given-names>S.N.</given-names></name><name><surname>Savinova</surname><given-names>O.V.</given-names></name><name><surname>Tolstikov</surname><given-names>G.A.</given-names></name></person-group><article-title>Lupane triterpenes and derivatives with antiviral activity</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2003</year><volume>13</volume><fpage>3549</fpage><lpage>3552</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(03)00714-5</pub-id><pub-id pub-id-type="pmid">14505668</pub-id></element-citation></ref><ref id="B63-plants-10-00041"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanmugam</surname><given-names>M.K.</given-names></name><name><surname>Nguyen</surname><given-names>A.H.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Tan</surname><given-names>B.K.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name></person-group><article-title>Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer</article-title><source>Cancer Lett.</source><year>2012</year><volume>320</volume><fpage>158</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2012.02.037</pub-id><pub-id pub-id-type="pmid">22406826</pub-id></element-citation></ref><ref id="B64-plants-10-00041"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pompei</surname><given-names>R.</given-names></name><name><surname>Flore</surname><given-names>O.</given-names></name><name><surname>Marccialis</surname><given-names>M.A.</given-names></name><name><surname>Pani</surname><given-names>A.</given-names></name><name><surname>Loddo</surname><given-names>B.</given-names></name></person-group><article-title>Glycyrrhizic acid inhibits virus growth and inactivates virus particles</article-title><source>Nature</source><year>1979</year><volume>281</volume><fpage>689</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1038/281689a0</pub-id><?supplied-pmid 233133?><pub-id pub-id-type="pmid">233133</pub-id></element-citation></ref><ref id="B65-plants-10-00041"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>M.</given-names></name><name><surname>Shigeta</surname><given-names>S.</given-names></name></person-group><article-title>Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro</article-title><source>Antivir. Res.</source><year>1987</year><volume>7</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(87)90025-8</pub-id><pub-id pub-id-type="pmid">3034150</pub-id></element-citation></ref><ref id="B66-plants-10-00041"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crance</surname><given-names>J.M.</given-names></name><name><surname>Scaramozzino</surname><given-names>N.</given-names></name><name><surname>Jouan</surname><given-names>A.</given-names></name><name><surname>Garin</surname><given-names>D.</given-names></name></person-group><article-title>Interferon, ribavirin, 6-azauridine and glycyrrhizin: Antiviral compounds active against pathogenic flaviviruses</article-title><source>Antivir. Res.</source><year>2003</year><volume>58</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(02)00185-7</pub-id><pub-id pub-id-type="pmid">12719009</pub-id></element-citation></ref><ref id="B67-plants-10-00041"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.-C.</given-names></name><name><surname>Cherng</surname><given-names>J.-M.</given-names></name><name><surname>Hung</surname><given-names>M.-S.</given-names></name><name><surname>Baltina</surname><given-names>L.A.</given-names></name><name><surname>Baltina</surname><given-names>L.</given-names></name><name><surname>Kondratenko</surname><given-names>R.</given-names></name></person-group><article-title>Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: Structure&#x02013;activity relationships</article-title><source>Antivir. Res.</source><year>2008</year><volume>79</volume><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2008.01.160</pub-id><pub-id pub-id-type="pmid">18423902</pub-id></element-citation></ref><ref id="B68-plants-10-00041"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahara</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>A.</given-names></name><name><surname>Shiraki</surname><given-names>K.</given-names></name></person-group><article-title>Effects of glycyrrhizin on hepatitis B surface antigen: A biochemical and morphological study</article-title><source>J. Hepatol.</source><year>1994</year><volume>21</volume><fpage>601</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/S0168-8278(94)80108-8</pub-id><pub-id pub-id-type="pmid">7814808</pub-id></element-citation></ref><ref id="B69-plants-10-00041"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>H.</given-names></name><name><surname>Takei</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Pollard</surname><given-names>R.B.</given-names></name><name><surname>Suzuki</surname><given-names>F.</given-names></name></person-group><article-title>Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients</article-title><source>Pathobiology</source><year>2002</year><volume>70</volume><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1159/000069334</pub-id><pub-id pub-id-type="pmid">12679601</pub-id></element-citation></ref><ref id="B70-plants-10-00041"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinatl</surname><given-names>J.</given-names></name><name><surname>Morgenstern</surname><given-names>B.</given-names></name><name><surname>Bauer</surname><given-names>G.</given-names></name><name><surname>Chandra</surname><given-names>P.</given-names></name><name><surname>Rabenau</surname><given-names>H.</given-names></name><name><surname>Doerr</surname><given-names>H.</given-names></name></person-group><article-title>Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>2045</fpage><lpage>2046</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)13615-X</pub-id><pub-id pub-id-type="pmid">12814717</pub-id></element-citation></ref><ref id="B71-plants-10-00041"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolkerstorfer</surname><given-names>A.</given-names></name><name><surname>Kurz</surname><given-names>H.</given-names></name><name><surname>Bachhofner</surname><given-names>N.</given-names></name><name><surname>Szolar</surname><given-names>O.H.</given-names></name></person-group><article-title>Glycyrrhizin inhibits influenza A virus uptake into the cell</article-title><source>Antivir. Res.</source><year>2009</year><volume>83</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2009.04.012</pub-id><pub-id pub-id-type="pmid">19416738</pub-id></element-citation></ref><ref id="B72-plants-10-00041"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sui</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>J.</given-names></name><name><surname>Ren</surname><given-names>X.</given-names></name></person-group><article-title>Antiviral effect of diammonium glycyrrhizinate and lithium chloride on cell infection by pseudorabies herpesvirus</article-title><source>Antivir. Res.</source><year>2010</year><volume>85</volume><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2009.10.014</pub-id><pub-id pub-id-type="pmid">19879899</pub-id></element-citation></ref><ref id="B73-plants-10-00041"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>M.E.</given-names></name><name><surname>Hendricks</surname><given-names>J.M.</given-names></name><name><surname>Paulson</surname><given-names>J.M.</given-names></name><name><surname>Faunce</surname><given-names>N.R.</given-names></name></person-group><article-title>18 &#x003b2;-glycyrrhetinic acid inhibits rotavirus replication in culture</article-title><source>Virol. J.</source><year>2012</year><volume>9</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/1743-422X-9-96</pub-id><pub-id pub-id-type="pmid">22214262</pub-id></element-citation></ref><ref id="B74-plants-10-00041"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>H.</given-names></name><name><surname>Lieberman</surname><given-names>P.M.</given-names></name></person-group><article-title>Mechanism of glycyrrhizic acid inhibition of Kaposi&#x02019;s sarcoma-associated herpesvirus: Disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>11159</fpage><lpage>11169</lpage><pub-id pub-id-type="doi">10.1128/JVI.00720-11</pub-id><?supplied-pmid 21880767?><pub-id pub-id-type="pmid">21880767</pub-id></element-citation></ref><ref id="B75-plants-10-00041"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashfaq</surname><given-names>U.A.</given-names></name><name><surname>Masoud</surname><given-names>M.S.</given-names></name><name><surname>Nawaz</surname><given-names>Z.</given-names></name><name><surname>Riazuddin</surname><given-names>S.</given-names></name></person-group><article-title>Glycyrrhizin as antiviral agent against Hepatitis C Virus</article-title><source>J. Transl. Med.</source><year>2011</year><volume>9</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/1479-5876-9-112</pub-id><?supplied-pmid 21762538?><pub-id pub-id-type="pmid">21762538</pub-id></element-citation></ref><ref id="B76-plants-10-00041"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chama</surname><given-names>M.A.</given-names></name><name><surname>Dziwornu</surname><given-names>G.A.</given-names></name><name><surname>Waibel</surname><given-names>R.</given-names></name><name><surname>Osei-Safo</surname><given-names>D.</given-names></name><name><surname>Addae-Mensah</surname><given-names>I.</given-names></name><name><surname>Otchere</surname><given-names>J.</given-names></name><name><surname>Wilson</surname><given-names>M.</given-names></name></person-group><article-title>Isolation, characterization, and anthelminthic activities of a novel dichapetalin and other constituents of <italic>Dichapetalum filicaule</italic></article-title><source>Pharm. Biol.</source><year>2016</year><volume>54</volume><fpage>1179</fpage><lpage>1188</lpage><?supplied-pmid 26118692?><pub-id pub-id-type="pmid">26118692</pub-id></element-citation></ref><ref id="B77-plants-10-00041"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojano</surname><given-names>B.</given-names></name><name><surname>Saez</surname><given-names>J.</given-names></name><name><surname>Schinella</surname><given-names>G.</given-names></name><name><surname>Quijano</surname><given-names>J.</given-names></name><name><surname>V&#x000e9;lez</surname><given-names>E.</given-names></name><name><surname>Gil</surname><given-names>A.</given-names></name><name><surname>Notario</surname><given-names>R.</given-names></name></person-group><article-title>Experimental and theoretical determination of the antioxidant properties of isoespintanol (2-Isopropyl-3, 6-dimethoxy-5-methylphenol)</article-title><source>J. Mol. Struct.</source><year>2008</year><volume>877</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2007.07.010</pub-id></element-citation></ref><ref id="B78-plants-10-00041"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>Y.B.</given-names></name><name><surname>Park</surname><given-names>S.-J.</given-names></name><name><surname>Kim</surname><given-names>Y.M.</given-names></name><name><surname>Lee</surname><given-names>J.-Y.</given-names></name><name><surname>Seo</surname><given-names>W.D.</given-names></name><name><surname>Chang</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Rho</surname><given-names>M.-C.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name></person-group><article-title>SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2010</year><volume>20</volume><fpage>1873</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.01.152</pub-id><pub-id pub-id-type="pmid">20167482</pub-id></element-citation></ref><ref id="B79-plants-10-00041"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>Y.</given-names></name><name><surname>Budzikiewicz</surname><given-names>H.</given-names></name></person-group><article-title>Pristimerin. Spectroscopic Properties of the Dienone&#x02014;Phenol-Type Rearrangement Products and Other Derivatives1</article-title><source>J. Org. Chem.</source><year>1965</year><volume>30</volume><fpage>1729</fpage><lpage>1734</lpage><pub-id pub-id-type="doi">10.1021/jo01017a006</pub-id></element-citation></ref><ref id="B80-plants-10-00041"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monache</surname><given-names>F.</given-names></name><name><surname>Bett&#x000f3;lo</surname><given-names>G.</given-names></name><name><surname>de Lima</surname><given-names>O.</given-names></name><name><surname>D&#x02019;Albuquerque</surname><given-names>I.</given-names></name><name><surname>de Barros</surname><given-names>C.J.</given-names></name></person-group><article-title>The structure of tingenone, a quinonoid triterpene related to pristimerin</article-title><source>J. Chem. Soc. Perkin Trans.</source><year>1973</year><volume>22</volume><fpage>2725</fpage><pub-id pub-id-type="doi">10.1039/P19730002725</pub-id><pub-id pub-id-type="pmid">4799459</pub-id></element-citation></ref><ref id="B81-plants-10-00041"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itokawa</surname><given-names>H.</given-names></name><name><surname>Shirota</surname><given-names>O.</given-names></name><name><surname>Ikuta</surname><given-names>H.</given-names></name><name><surname>Morita</surname><given-names>H.</given-names></name><name><surname>Takeya</surname><given-names>K.</given-names></name><name><surname>Iitaka</surname><given-names>Y.</given-names></name></person-group><article-title>Triterpenes fromMaytenus ilicifolia</article-title><source>Phytochemistry</source><year>1991</year><volume>30</volume><fpage>3713</fpage><lpage>3716</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(91)80096-J</pub-id></element-citation></ref><ref id="B82-plants-10-00041"><label>82.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pomponi</surname><given-names>M.</given-names></name><name><surname>Delle Monache</surname><given-names>F.</given-names></name></person-group><source>&#x0201c;Rearrangements of Tingenone.&#x0201d; IV. Researches on Quinonoid Triterpenes</source><publisher-name>Real Sociedad Espa&#x000f1;ola de Qu&#x000ed;mica</publisher-name><publisher-loc>Madrid, Spain</publisher-loc><year>1974</year></element-citation></ref><ref id="B83-plants-10-00041"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotanaphun</surname><given-names>U.</given-names></name><name><surname>Lipipun</surname><given-names>V.</given-names></name><name><surname>Suttisri</surname><given-names>R.</given-names></name><name><surname>Bavovada</surname><given-names>R.</given-names></name></person-group><article-title>Antimicrobial activity and stability of tingenone derivatives</article-title><source>Planta Med.</source><year>1999</year><volume>65</volume><fpage>450</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1055/s-2006-960809</pub-id><pub-id pub-id-type="pmid">10418334</pub-id></element-citation></ref><ref id="B84-plants-10-00041"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotanaphun</surname><given-names>U.</given-names></name><name><surname>Lipipun</surname><given-names>V.</given-names></name><name><surname>Yaipakdee</surname><given-names>P.</given-names></name><name><surname>Bavovada</surname><given-names>R.</given-names></name></person-group><article-title>New acidic-rearranged compounds from tingenone derivatives and their biological activity</article-title><source>Pharm. Biol.</source><year>2005</year><volume>43</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1080/13880200590903345</pub-id></element-citation></ref><ref id="B85-plants-10-00041"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Nakashima</surname><given-names>H.</given-names></name><name><surname>Baba</surname><given-names>M.</given-names></name><name><surname>Pauwels</surname><given-names>R.</given-names></name><name><surname>De Clercq</surname><given-names>E.</given-names></name><name><surname>Shigeta</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name></person-group><article-title>Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]</article-title><source>Antivir. Res.</source><year>1987</year><volume>7</volume><fpage>127</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(87)90001-5</pub-id><pub-id pub-id-type="pmid">3475037</pub-id></element-citation></ref><ref id="B86-plants-10-00041"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ushio</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>H.</given-names></name></person-group><article-title>Inactivation of measles virus and herpes simplex virus by saikosaponin d</article-title><source>Planta Med.</source><year>1992</year><volume>58</volume><fpage>171</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1055/s-2006-961422</pub-id><?supplied-pmid 1529029?><pub-id pub-id-type="pmid">1529029</pub-id></element-citation></ref><ref id="B87-plants-10-00041"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>G.S.</given-names></name><name><surname>Sinsheimer</surname><given-names>J.E.</given-names></name><name><surname>Cochran</surname><given-names>K.W.</given-names></name></person-group><article-title>Antiviral activity of triterpenoid saponins containing acylated &#x003b2;-amyrin aglycones</article-title><source>J. Pharm. Sci.</source><year>1974</year><volume>63</volume><fpage>471</fpage><lpage>473</lpage><?supplied-pmid 4820390?><pub-id pub-id-type="pmid">4820390</pub-id></element-citation></ref><ref id="B88-plants-10-00041"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amoros</surname><given-names>M.</given-names></name><name><surname>Fauconnier</surname><given-names>B.</given-names></name><name><surname>Girre</surname><given-names>R.</given-names></name></person-group><article-title>In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus</article-title><source>Antivir. Res.</source><year>1987</year><volume>8</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(87)90084-2</pub-id><pub-id pub-id-type="pmid">2825589</pub-id></element-citation></ref><ref id="B89-plants-10-00041"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhuri</surname><given-names>S.K.</given-names></name><name><surname>Fullas</surname><given-names>F.</given-names></name><name><surname>Brown</surname><given-names>D.M.</given-names></name><name><surname>Wani</surname><given-names>M.C.</given-names></name><name><surname>Wall</surname><given-names>M.E.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Mar</surname><given-names>W.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Zaw</surname><given-names>K.</given-names></name></person-group><article-title>Isolation and structural elucidation of pentacyclic triterpenoids from Maprounea africana</article-title><source>J. Nat. Prod.</source><year>1995</year><volume>58</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1021/np50115a001</pub-id><?supplied-pmid 7760064?><pub-id pub-id-type="pmid">7760064</pub-id></element-citation></ref><ref id="B90-plants-10-00041"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rut</surname><given-names>W.</given-names></name><name><surname>Lv</surname><given-names>Z.</given-names></name><name><surname>Zmudzinski</surname><given-names>M.</given-names></name><name><surname>Patchett</surname><given-names>S.</given-names></name><name><surname>Nayak</surname><given-names>D.</given-names></name><name><surname>Snipas</surname><given-names>S.J.</given-names></name><name><surname>El Oualid</surname><given-names>F.</given-names></name><name><surname>Bekes</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>T.T.</given-names></name><name><surname>Drag</surname><given-names>M.</given-names></name></person-group><article-title>Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design</article-title><source>bioRxiv</source><year>2020</year><volume>6</volume><fpage>eabd4596</fpage></element-citation></ref><ref id="B91-plants-10-00041"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekerman</surname><given-names>E.</given-names></name><name><surname>Neveu</surname><given-names>G.</given-names></name><name><surname>Shulla</surname><given-names>A.</given-names></name><name><surname>Brannan</surname><given-names>J.</given-names></name><name><surname>Pu</surname><given-names>S.-Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Xiao</surname><given-names>F.</given-names></name><name><surname>Barouch-Bentov</surname><given-names>R.</given-names></name><name><surname>Bakken</surname><given-names>R.R.</given-names></name><name><surname>Mateo</surname><given-names>R.</given-names></name></person-group><article-title>Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects</article-title><source>J. Clin. Investig.</source><year>2017</year><volume>127</volume><fpage>1338</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1172/JCI89857</pub-id><pub-id pub-id-type="pmid">28240606</pub-id></element-citation></ref><ref id="B92-plants-10-00041"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>C.</given-names></name><name><surname>Ginex</surname><given-names>T.</given-names></name><name><surname>Maestro</surname><given-names>I.</given-names></name><name><surname>Nozal</surname><given-names>V.</given-names></name><name><surname>Barrado-Gil</surname><given-names>L.</given-names></name><name><surname>Cuesta-Geijo</surname><given-names>M.A.</given-names></name><name><surname>Urquiza</surname><given-names>J.</given-names></name><name><surname>Ram&#x000ed;rez</surname><given-names>D.</given-names></name><name><surname>Alonso</surname><given-names>C.</given-names></name><name><surname>Campillo</surname><given-names>N.E.</given-names></name></person-group><article-title>COVID-19: Drug targets and potential treatments</article-title><source>J. Med. Chem.</source><year>2020</year><volume>63</volume><fpage>12359</fpage><lpage>12386</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c00606</pub-id><pub-id pub-id-type="pmid">32511912</pub-id></element-citation></ref><ref id="B93-plants-10-00041"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantini</surname><given-names>F.</given-names></name><name><surname>Banci</surname><given-names>L.</given-names></name><name><surname>Altincekic</surname><given-names>N.</given-names></name><name><surname>Bains</surname><given-names>J.</given-names></name><name><surname>Dhamotharan</surname><given-names>K.</given-names></name><name><surname>Fuks</surname><given-names>C.</given-names></name><name><surname>F&#x000fc;rtig</surname><given-names>B.</given-names></name><name><surname>Gande</surname><given-names>S.</given-names></name><name><surname>Hargittay</surname><given-names>B.</given-names></name><name><surname>Hengesbach</surname><given-names>M.</given-names></name></person-group><article-title>1 H, 13 C, and 15 N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b</article-title><source>Biomol. NMR Assign.</source><year>2020</year><volume>14</volume><fpage>339</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1007/s12104-020-09973-4</pub-id><pub-id pub-id-type="pmid">32803496</pub-id></element-citation></ref><ref id="B94-plants-10-00041"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michalska</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Jedrzejczak</surname><given-names>R.</given-names></name><name><surname>Maltseva</surname><given-names>N.I.</given-names></name><name><surname>Stols</surname><given-names>L.</given-names></name><name><surname>Endres</surname><given-names>M.</given-names></name><name><surname>Joachimiak</surname><given-names>A.</given-names></name></person-group><article-title>Crystal structures of SARS-CoV-2 ADP-ribose phosphatase (ADRP): From the apo form to ligand complexes</article-title><source>bioRxiv</source><year>2020</year><volume>7</volume><fpage>814</fpage><lpage>824</lpage></element-citation></ref><ref id="B95-plants-10-00041"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>M.</given-names></name><name><surname>Ma</surname><given-names>C.-M.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Dine</surname><given-names>R.</given-names></name><name><surname>Sato</surname><given-names>N.</given-names></name></person-group><article-title>Survey of anti-HIV and anti-HCV compounds from Natural sources</article-title><source>Can Chem. Trans.</source><year>2013</year><volume>1</volume><fpage>116</fpage><lpage>140</lpage></element-citation></ref><ref id="B96-plants-10-00041"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>B.-S.</given-names></name><name><surname>Nakamura</surname><given-names>N.</given-names></name><name><surname>Miyashiro</surname><given-names>H.</given-names></name><name><surname>BAE</surname><given-names>K.-W.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name></person-group><article-title>Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease</article-title><source>Chem. Pharm. Bull.</source><year>1998</year><volume>46</volume><fpage>1607</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1248/cpb.46.1607</pub-id><?supplied-pmid 9810695?><pub-id pub-id-type="pmid">9810695</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="plants-10-00041-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Pie charts indicating the distribution of chemical subclasses of steroids (<bold>A</bold>) and triterpenes (<bold>B</bold>).</p></caption><graphic xlink:href="plants-10-00041-g001a"/><graphic xlink:href="plants-10-00041-g001b"/></fig><fig id="plants-10-00041-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Pie charts indicating the biological activities of steroids (<bold>A</bold>) and triterpenes (<bold>B</bold>).</p></caption><graphic xlink:href="plants-10-00041-g002a"/><graphic xlink:href="plants-10-00041-g002b"/></fig><fig id="plants-10-00041-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The 2D and 3D chemical structures of virus reverse transcriptase inhibitors.</p></caption><graphic xlink:href="plants-10-00041-g003a"/><graphic xlink:href="plants-10-00041-g003b"/><graphic xlink:href="plants-10-00041-g003c"/><graphic xlink:href="plants-10-00041-g003d"/></fig><fig id="plants-10-00041-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>The 2D and 3D chemical structures of virus protease inhibitors.</p></caption><graphic xlink:href="plants-10-00041-g004a"/><graphic xlink:href="plants-10-00041-g004b"/></fig><fig id="plants-10-00041-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>The 2D and 3D chemical structures of virus replication inhibitors.</p></caption><graphic xlink:href="plants-10-00041-g005a"/><graphic xlink:href="plants-10-00041-g005b"/></fig><fig id="plants-10-00041-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>The 2D and 3D chemical structures of other antiviral compounds.</p></caption><graphic xlink:href="plants-10-00041-g006a"/><graphic xlink:href="plants-10-00041-g006b"/><graphic xlink:href="plants-10-00041-g006c"/><graphic xlink:href="plants-10-00041-g006d"/><graphic xlink:href="plants-10-00041-g006e"/></fig><fig id="plants-10-00041-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Top-scoring triterpenes retrieved from docking against both viral and human-based targets. Hits for 5 targets (Green color), hits for 2 targets (Orange color), and hits for only one target (Black color).</p></caption><graphic xlink:href="plants-10-00041-g007"/></fig><fig id="plants-10-00041-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Binding modes of 1&#x000df;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11) inside SARS-CoV-2 targets. (<bold>B</bold>,<bold>D</bold>) Interactions inside both M<sup>pro</sup> and PL<sup>pro</sup>, respectively. (<bold>A</bold>,<bold>C</bold>) co-crystallized ligands of both M<sup>pro</sup> and PL<sup>pro</sup>, respectively.</p></caption><graphic xlink:href="plants-10-00041-g008"/></fig><fig id="plants-10-00041-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Binding modes of 1&#x000df;-Hydroxyaleuritolic acid 3-<italic>p</italic>-hydroxybenzoate (11) inside the human-based targets. (<bold>B</bold>,<bold>D</bold>,<bold>F</bold>) Interactions inside both AAK1, cathepsin L, and furin, respectively. (<bold>A</bold>,<bold>C</bold>,<bold>E</bold>) co-crystallized ligands of AAK1, cathepsin L, and furin, respectively.</p></caption><graphic xlink:href="plants-10-00041-g009"/></fig><fig id="plants-10-00041-f010" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Binding modes of Ganoderiol F (14) inside the viral and human-based targets. (<bold>B</bold>,<bold>D</bold>) Interactions inside both ARP and furin, respectively. (<bold>A</bold>,<bold>C</bold>) co-crystallized ligands of ARP and furin, respectively.</p></caption><graphic xlink:href="plants-10-00041-g010"/></fig><fig id="plants-10-00041-f011" orientation="portrait" position="float"><label>Figure 11</label><caption><p>Binding modes of Suberosol (16) inside the human-based targets. (<bold>B</bold>,<bold>D</bold>) Interactions inside both AAK1 and GAK, respectively. (<bold>A</bold>,<bold>C</bold>) co-crystallized ligands of AAK1 and GAK, respectively.</p></caption><graphic xlink:href="plants-10-00041-g011"/></fig><fig id="plants-10-00041-f012" orientation="portrait" position="float"><label>Figure 12</label><caption><p>Binding modes of 20(21)-dehydrolucidenic acid (<bold>B</bold>) (12), Ganodermanondiol (<bold>D</bold>) (13), and Lucidumol A (<bold>E</bold>) (15) inside the viral and human-based targets (GAK and ARP, respectively). (<bold>A</bold>,<bold>C</bold>) co-crystallized ligands of GAK and ARP, respectively.</p></caption><graphic xlink:href="plants-10-00041-g012"/></fig><table-wrap id="plants-10-00041-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">plants-10-00041-t001_Table 1</object-id><label>Table 1</label><caption><p>Binding free energies in kcal/mol of the top-scoring triterpenes against 7 viral and non-viral targets (3 viral-based and 4 human-based).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ARP (6W02)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">M<sup>pro</sup><break/>(6LU7)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PL<sup>pro</sup><break/>(6WXR)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AAK1 (4WSQ)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">GAK (4Y8D)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cathepsin L(2YJC)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Furin (6EQX)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>1&#x000df;-Hydroxyaleuritolic acid 3-p-hydroxy-benzoate (11)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;-4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>20(21)-dehydrolucidenic acid (12)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Ganodermanondiol (13)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;-4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Ganoderiol F (14)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;8.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Lucidumol A (15)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;9.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Suberosol (16)</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;8.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;&#x02212;4</td></tr></tbody></table></table-wrap></floats-group></article>